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Introduction
HISTORY OF HEREDITARY HEARING LOSS
After the French revolution a rapid conversion of hospitals from their hospice activity 
into new centres of medical life occurred.
Correlation between clinical signs and pathological evidence revolutionized clinical medicine and at 
the same time provided scientific basis for the rise of new medical specialties. France was the first 
country to remove otology from the sphere of the general surgeon.
France was soon followed by other countries as Great-Britain, Germany and Austria, having eminent 
and pionering otologists. Some of those pioneers from the 18th century showed great interest in the 
understanding of the genetic causes of inner ear deafness like the Irish otologist Sir William Wilde 
(1815-1876). In 1841 he was appointed Medical Commissioner for the Irish Census.1 Based on 
questions on presence of deafness in family members put into the census he succeeded to trace 
families with deafness.
So, he was the first to report on pedigrees with a “direct” (autosomal dominant) way of transmission 
of deafness and acknowledged that heredity is a cause of hearing impairment in man.2 
Another remarkable historical fact is the first report on what is nowadays called the autosomal 
recessive inherited Usher syndrome by the famous Berlin ophthalmologist Albrecht von Graefe. He 
described this syndrome in three "deaf-blind" brothers from only one family.3
Only a few years previously the ophthalmoscope had become available for clinical application and as 
a consequence, his nephew, Alfred Graefe, realised at his Berlin clinic that the congenital deafness in 
these three children, together with the diagnosis of co-existing retinitis pigmentosa, must be the result 
of a hereditary pattern. Finally it was Charles Usher who gave his name to this syndrome in a 
Bowman lecture in 1935.4 As elucidated recently in a thesis on Usher syndrome an in-depth 
description of this syndrome was published in 1861 by the Berlin ophthalmologist, Liebreich.5 He 
performed a systematic examination of the deaf population in Berlin, which totalled 341 persons, and 
was amazed by the reatively high incidence of retinitis pigmentosa among the deaf, particularly in 
those with a Jewish background.6
Moreover, the high consanguinity ratio among the parents of the affected persons was striking. The 
incidence of congenital deafness (1:368) among Jews in Berlin at that time
was higher than among the remaining population (1:1477). It was clear that the higher consanguinity 
ratio among Jews played a role in this.
So besides the direct way of transmission also an “indirect” way of transmission of genetic deafness
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was identified.
It was understood that consanguinity raised this risk and that the way of transmission passed several 
generations before showing its outcome.
Similar observations took place in Germany. Hartmann (1880) published pedigrees with inherited 
deafness over generations. 7 Reports in the Netherlands by de Wilde 8 (1913) and in Norway by 
Uchermann9 (1869) confirmed the correlation between an elevated consanguinity ratio and the 
incidence of profound childhood deafness.
Adam Politzer considered as the father of modern otology taught otology in Vienna to several 
generations of post-graduate students from all over the world.
In his second edition of the "Lehrbuch der Ohrenheilkunde" (1887); translated into English, Italian 
and Spanish and ran five editions he stressed genetics as an important cause of deafness. He described 
clearly the direct and the indirect way of transmission of genetic deafness. It was not until this second 
edition that heredity as an etiology of hearing impairment became an accepted concept in western 
otology.10
Politzer found this teaching on the genetics of deafness primarily on the studies of Hartmann. Politzer 
presented statistics confirming Wilde's and Uchermann's studies on the rate of consanguinity and the 
rate of profound childhood deafness.
Discovery of Mendel’s laws at the start of the 20th century clarified and enhanced understanding of 
previously unclarified patterns of inheritance.11
Also in the Netherlands several reports on syndromal deafness were presented; “Retinitis en doofheid 
” by de Wilde in 1913 8; reports on osteogenesis imperfecta by van der Hoeve and de Kleyn (1917) 12 
and a clinical description on Waardenburg syndrome (1951)13 
are good examples.
Knowledge about the syndromal and non-syndromal forms of hereditary hearing loss increased 
strongly in the second half of this century. In the last decades of this century the number of inherited 
syndromes with hearing loss has exceeded more than 400.
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Chapter 1
Today syndromal catalogues as well as internet facilities exist to establish a most optimal syndromal
J- • 14,15diagnosis.
The availability of the audiometer after the second world war enabled physicians to recognize 
consistent differences in the audiograms of different families and make distinctions between different 
forms of sensorineural hearing loss. In this way, distinctions could be made between families with 
low frequency, mid-frequency and high frequency hearing loss.
Koningsmark was the first author of these references and together with Gorlin in the 1970's, he made 
it credible that several distinct mutant alleles are involved in these subtypes of non-syndromic 
sensorineural hearing loss. 16
Recent surveys indicate that the incidence of genetic hearing loss in Western Europe occurs with a 
prevalence of about 1,27 in 1000 births. 17 (average hearing level in the best ear > 25 dB). A review 
study by Morton18 estimates the incidence of autosomal recessive patterns approximately 77%. 
Mostly this hearing loss presents early and is in most cases prelingual and severe. Autosomal 
dominant patterns of inheritance occur in 22% and mostly as postlingual hearing loss. The incidence 
of X-linked hearing loss is 1% whereas mitochondrial hearing loss occurs sporadic although no 
detailed investigation of incidence of maternal patterns in hearing loss has ever been made.
Gene linkage studies started for genetic types of hearing impairment in the late 1970's in the 
Netherlands. First of all the focus was on syndromal hearing impairments to trace their chromosomal 
locations. A synopsis of the most frequently encountered syndromes with their sofar cloned genes are 
displayed in Table I.
More recently same attention has been given to the non-syndromal types of genetic hearing 
impairment. It took until the 1990's before assumed distinctions in genotype based on the phenotype 
could be confirmed with the new technique of gene linkage. At the same time it appeared that several 
genotypes could be responsible for the same type of audiometric curves (phenotypes). However, still 
today, careful analysis of the audiological data will enable the description and prediction of the type 
of hearing impairment caused by a specific gene in the various families.
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Table 1.
Genes causing inherited diseases with syndromal hearing loss.
Autosomal recessive Linkage Gene cloned References
Usher type IA 14q32 Kaplan 19
Usher type IB 11q 13.5 MYO7A Weil 20
Usher type IC 11p 11.15.1 Smith21
Usher type ID 10 Wayne22
Usher type IE 2 1 q21 Chaib23
Usher type IF 10 Wayne24
Usher type IIA 1q41 USH2A Eudy 25
Usher type IIB 3p23-24.2 Hmani 26
Usher type IIC 5q14.3-q21.3 Pieke Dahl 27
Usher type III 3q Sankila28
Pendred syndrome 7q PDS Everett 29
Jervel Lange Nielsen 11p 15.5;2 1 q 22.1 KVLQT1; KCNE1 Neyroud30;Tyson 31
Alport syndrome 2 q COL4A3 ;COL4A4 Mochizuki 32
Renal tubular acidosis 2 cen q13 ATP6B1 Karet 33
X-linked
Norrie disease X pn .3 NORRIN Chen 34
Alport syndrome Xq2i-22 COL4A5 Barker 35
Stapes- gusher Xq21 POU4F3 De Kok 36
Autosomal dominant
Branchio-oto-renal 8q EYA1 Abdelhak 37
Treacher Collins 5q 31.3-32 TCOF1 Dixon 38
Stickler type 1 12q13.11-13.2 COL2A1 Williams39
Stickler type II 6 p21.3 COL11A2 Vikkula 40
Stickler type III 1p21 COL11A1 Richards 41
Waardenburg type I 2q35 PAX2 Tassabehji42
Waardenburg type II 3p14.1-12.3 MITF Tassabehji44
Waardenburg type III 2q35 PAX2 Hoth 43
Crouzon syndrome 10q26 PAX2,FGFR2 Reardon45
Saethre-Chotzen syndrome 7p21 TWIST,FGFR2,3 houzzi46Howard47
Osteogenesis imperfecta type I 7q22.1;17q21.3-33.05 COL1A1; COL1A2 Sykes48
Piebald trait 4 q 11-12 KIT Spritz49
Riegers syndrome 4q26;13q14 PITX2 Semina50; Philips'
Proximal symphalangism 17q21 NOGGIN Gong 52
Charcot-Marie-T ooth 17p11.2-p12 PMP22 Kovach53
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Table II shows the different loci related to autosomal dominant non-syndromic sensorineural hearing
, 54-80loss.
Table 2.
Chromosomal location o f genes causing non-syndromal autosomal dominant hearing loss.
Autosomal dominant Linkage Gene Cloned References
DFNA
DFNA 1 5q3i HD1A1 Lynch 54
DFNA 2 1p34 GJB3; KCNQ4 Xia 55;Kubisch56
DFNA 3 13qi2 GJB2, Denoyelle57
GJB6 Grifa58
DFNA 4 19qi3 Chen 59
DFNA 5 7pi5 DFNA5 Van Laer 60
DFNA 6 4pi6.3 Lesperance 61
DFNA 7 1q21-q23 Fagerheim 62
DFNA 8 iiq22-24 TECTA Verhoeven 63
DFNA 9 14qi2-q13 COCH Robertson 64
DFNA 10 6q22-q23 O ‘Neill 65
DFNA 11 11qi2.3-q21 MYO7A Liu 66
DFNA 12 11q22-q24 TECTA Verhoeven 63
DFNA 13 6p21 COL11A2 Mc Guirt 67
DFNA 14 4pi6 Van Camp 68
DFNA 15 5q3i POU4F3 Vahava 69
DFNA 16 2q24 Fukishima 70
DFNA 17 22q Lalwani 71
DFNA 18 3q22 Boensch 72
DFNA 19 per10 Green 73
DFNA 20 reserved Friderici 74
DFNA 21 reserved
DFNA 22 reserved
DFNA 23 14q Salam75
DFNA 24 4q Hafner76
DFNA 25 12q21-24 Greene77
DFNA 26 17q25
DFNA 27 4qi2 Fridell78
DFNA 28 8q22 Anderson79
DFNA 29 reserved
DFNA 30 15q26 Mangino80
DFNA 31-36 reserved
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MITOCHONDRIAL HEARING LOSS.
Gene linkage into causes of maternally inherited diseases are characterized by rapid identifications of 
the responsible mitochondrial defects in the respiratory chain.
The small size of the mitochondrial genome; 16659 base pairs with a clarified sequence, accounts for 
this. Although the first reports on mitochondrial involvement 81 originate from 1962, the first 
responsible defect was found in 1988.
In most maternally inherited syndromes neurological and ophthalmological symptoms dominate. 
Hearing loss is in most cases an associated symptom. Two mitochondrial mutations are responsible 
for non-syndromal deafness. The substitution of an Adenosine for Guanosine at position 1555 of an r- 
RNA gene was found in an Arab-Israelian family and reported in consecutive families from Spain and 
Zaire.82-85
This mutation is also associated with high susceptibility to regular dosis of aminoglycosides.86 The 
2nd mutation that causes non-syndromal hearing loss consists of a Cytosine to Guanosine substitution 
at position 7445 of an t-RNA gene and was reported in families from New Zealand and Scotland. 87-88
DEVELOPMENT OF THIS THESIS.
As result of a long tradition of family studies, and also because gene linkage studies for non- 
syndromic hearing loss evolved rapidly at the start of this study two PhD-thesis projects (R. Ensink 
and D. Kunst) were started to collect and study large families with a dominant pattern of inheritance 
for hearing impairment. The gene-linkage studies in this thesis were performed by the Department of 
Human Genetics, University of Antwerp (Dr. G. Van Camp, Dr. K. Verhoeven, Prof. dr. P. 
Willems).
AIMS OF THIS STUDY.
1: To promote gene linkage in syndromic as well as in non-syndromic dominant hearing loss. To 
identify genotypes responsible for phenotypes.
2: Analyzing the audiological and neurological characteristics of a maternallly transmitted
hearing loss. Identification of the responsible respiratory chain defect in individuals with maternally 
inherited hearing loss. (Cins 7472)
3: To give clinical descriptions of several syndromes with congenital conductive hearing loss. 
To describe possible surgical reconstruction of the auditory chain of ossicles.
16
Chapter 1
THE STUDY POPULATION.
Most patients that participated in this thesis were seen at the department of Otorhinolaryngology of 
the University Hospital Nijmegen. Selected patients (chapter 2) were seen at the the departments of 
Ophthalmology (consultant Dr. A. Pinckers f) and
Neurology (consultant Prof. Dr. GW. Padberg) and the Institute for Neurogenetics and Morfology 
(Dr. H. ter Laak and Dr. W. Ruitenbeek). For counselling and description of the four clinical 
phenotypes that constitute chapter 4 we were helped by the department of Human Genetics Nijmegen 
(Prof. Dr. H. Brunner).
The ear surgery was performed at the departments of Otorhinolaryngology of the University Hospital 
Nijmegen ( Prof. Dr. CWRJ Cremers.) and St. Camillus Hospital, Antwerp, Belgium. (Dr. JP. 
Sleeckx)
STUDY METHODS.
For the family studies, all family’s were approached by their probands, who were in most cases 
known with a hearing loss and/or additional complaints for a longer period at the Nijmegen 
department of Otorhinolaryngology. With help of these probands a pedigree was constructed and all 
branches were approached separately for participation in the research. We tried to trace large families 
with at least 15 affected individuals that facilitated linkage analysis. All participants received an 
explanation about the aim of the study and gave their permission to obtain audiograms and relevant 
medical information from elswhere. By this it was also possible to obtain sufficient audiological data 
for longitudinal research of hearing loss as was performed in nearly all family studies. Medical 
examination of the affected persons was in the non-syndromic hearing loss aimed at the ear and 
vestibular organ. In most cases a general otorhinolaryngological examination was performed. 
Audiological examination compromised otoscopy, tone audiometry and speech audiometry. Brain 
stem audiometry and vestibular testing with the aid of a rotatory chair and electro-nystagmography 
was performed in some cases. In the family with the maternal trait of hearing impairment special 
attention was given to diabetes mellitus; neurological symptoms and signs of tapetoretinal 
degeneration. An ophthalmological and neurological examination were performed in selected cases. 
Besides this an neurological questionaire was send to identify the neurological complaints. In all case 
reports radiological examination of the petrosal bones was performed.
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GENE LINKAGE STUDIES.
Gene linkage studies of the families mentioned in chapter 2 and 3 were performed at the department 
of Human Genetics of the University of Antwerp. (Dr. G. Van Camp; Dr. K. Verhoeven and Prof. Dr. 
P. Willems). Gene linkage studies for the two families with proximal symphalangism were performed 
at the Nijmegen department of Human Genetics. In all informative persons 20cc blood was taken on 
their visit to the out-patient clinic or in some families at their homes. The heteroplasmia values in the 
family with the mitochondrial disorder were investigated by Dr. M. Zeviani, Institute for 
Neurogenetics, Robertson Institute, Milan, Italy. Dr. N. Fischel-Ghodsian, Cedars Centre of Research 
Studies Los Angeles, United States, excluded the 7472 Cytosine insertion in his group of individuals 
with aminoglycoside induced deafness.
It was for the group a surprise to run into the opportunity to study an until now very rare 
mitochondrial determined type of progressive sensorineural hearing loss (Mt 7472). The responsible 
mutation, previously only described in a small Sicilian family, consists of a insertion of an extra C at 
position 7472 of the mitochondrial genome.89 The same mutation was also recently found in neonates 
with COX deficiancy. Probably a homoplasmic drift explains these fatal neurological manifestation of 
the disease.90 So, clinical manifestations of this C-insertion seem to vary with levels of heteroplasmia. 
Although in some isolated cases as well in the Sicilian family neurological symptoms such as ataxia, 
focal myoclonus and epilepsia partialis continua with lactic acidosis and mental retardation dominate 
89,91 , in our family the sensorineural hearing loss was more pronounced. The results of this family 
study as well as an introduction to mitochondrial inherited hearing loss are given in chapter 2.
Chapter 3 reports on the clinical and genetic findings in 2 large families with an autosomal dominant 
type of progressive high frequency sensorineural hearing loss. Families with DFNA2 have been found 
living in Indonesia, Flandres, USA and the Netherlands.92 Two deafness genes in the DFNA2 region 
have been identified. 55,56 In the Dutch families (Dutch I-III) the gene was identified as KCNQ4, a 
novel member of the KCNQ4 voltage gated K+ channel. Several missense mutations are discovered 
altering the P loop or pore region of this channel. 93 The responsible gene defect in Dutch III , 
reported in this thesis, alters the Kalium ion transporting channel. 94
18
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A correlation between phenotype and genotype is presented here in this thesis. 95 For the remaining 
family with autosomal dominant late-onset sensorineural hearing impairment the gene linkage studies 
disclosed linkage to DFNA13 , localized on chromosome 6, however no mutation was detected in 
COL11A2.
Chapter 4 of this thesis reports mainly on the otological aspects of four rare syndromes with 
congenital conductive hearing loss. In approximately 1/3 of inherited hearing loss with anomalies of 
the ossicular chain, the hearing loss is part of a syndrome. Knowledge of the complexity of the 
ossicular chain is seldom reported in detail. However pre-operative radiological examination of 
middle and inner ear and knowledge of the existing syndromal diagnosis helps the final decision 
making to perform reconstructive middle ear surgery.96 The Saethre-Chotzen syndrome, Lacrimo- 
Auriculo-Dental-Digital (LADD) syndrome and proximal symphalangism all have autosomal 
dominant traits. Linkage for the Saethre- Chotzen syndrome is established to 7p and for proximal 
symphalangism to 17q. In the latter syndrome the gene was identified as NOGGIN. The fourth 
reported syndrome has many characteristics of Treacher Collins syndrome; however the pattern of 
inheritance remains yet unclear. Chapter 4 therefore fits in the "Nijmegen interests" to describe in 
detail syndromes with congenital conductive hearing loss.97,98
Chapter 5 gives final conclusions and discusses as well as reflects on research on inherited hearing 
loss in the future.
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INTRODUCTION.
Only recently it has been established that mutations in the mitochondrial DNA (mt DNA) are 
associated with a variety of hearing defects. This review article outlines the clinical spectrum of these 
mutations, explains the basic principles of mitochondrial genetics and discusses the remaining 
challanges and clinical relevance of investigating a maternally inherited hearing loss. We will discuss 
currently known mutations leading to syndromic or non-syndromic hearing impairment.
HISTORY.
In 1962 the first research in mitochondrial diseases was initiated by Luft and co-workers.1 They 
reported on a patient with non-thyroidal hypermetabolism whose muscle mitochondria revealed 
characteristic para-crystalline inclusions.
The following two decades investigations on mitochondrial diseases were mainly dominated by 
clinical and morfological descriptions, displaying the characteristic ragged-red muscle fibers. These 
clinical descriptions were mainly confined to patients with myopathies.
In 1988 a breakthrough in mitochondrial pathofysiology occurred with the first reports of pathogenic 
mtDNA mutations in neuromuscular disorders with mitochondrial involvement.2,3 Since then the 
number of pathogenic mitochondrial mutations has expanded rapidly and was found to cause a broad 
spectrum of overlapping clinical entities. The first identification of a mitochondrial mutation 
responsible for non-syndromal hearing loss originates from 1992 and was detected in an Arab-Israelic 
family.4
The discovery of pathogenic mitochondrial mutations has provided the molecular basis for non- 
Mendelian maternal inheritance. The incidence of mitochondrial mutations in genetic hearing loss is 
still largely unknown but may be more frequent than can be estimated from current literature studies.
MITOCHONDRIAL GENETICS; STRUCTURE AND COMPLEX DEFICIANCIES.
The most important mitochondrial function is the synthesis of ATP by oxidative phosphorylation. 
Mitochondrial failure to generate ATP leads to excessive lactic acid production due to anaerobic 
degradation of glucose. Excessive lactic acid is a feature of many mitochondrial myopathies.
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The mitochondrial DNA encodes in cooperation with nuclear DNA for several proteins that form five 
enzyme complexes situated in the inner mitchondrial membrane. These complexes are involved in 
ATP generation. ATP generation is performed with the help of specific co-factors. Each human 
mitochondrium contains an average of 6 circular organized mitochondrial chromosomes. Each 
chromosome consists of 16569 basepairs.
In the normal situation all cells carry exactly identical copies of mt DNA; a phenomenon known as 
homoplasmy. However different mitochondrial genotypes may occur in the same cell; a phenomenon 
called heteroplasmy. Since normal cel division can lead to random distribution of mitochondria to 
daughter cells this random distribution leads to changes in heteroplasmy. This process is referred to as 
replicative segregation.5 In most cases heteroplasmy is associated with a disease. MtDNA is 
exclusively transmitted through mothers (maternal inheritance). The sperm cell apparantly 
contributes no mitochondria to the zygote.6 This implicates that fathers affected with a mitochondrial 
disease generally have normal children. A typical pedigree exhibiting maternal or mitochondrial 
inheritance is outlined in Figure 1.
Figure 1.
A defect in a mitochondrial gene (point-mutation) leads to variable manifestation of disease in both sexes, but 
transmission only occurs through the maternal line. Squares represent males; circles females. Black indicates 
full manifestation of disease; gray intermediate; white no disease. Dotted figures represent carriers without 
manifestation of the mitochondrial inherited disease.
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THE PHENOTYPIC SPECTRUM OF MITOCHONDRIAL DISEASE.
Variety in the clinical manifestation of mitochondrial diseases was already recognized far before the 
identification of the responsible mutations. Frequent clinical features include myopathy and a wide 
range of CNS dysfunction, endocrine and renal dysfunctions as well as cardiac conduction defects.8 
Tissues that highly depend on maintaining high energy levels for their metabolism (retina, brainstem, 
cardiac muscle, pancreas and cochlea) are most frequently involved. The detection of responsible 
mitochondrial mutations demonstrated also that considerable clinical overlap occurs in genetically 
distinct conditions. On the other hand identical mitochondrial mutations can cause different clinical 
entities. Table 1 summarizes the main clinical manifestations.
TABLE 1
Manifestations of mitochondrial encephalomyopathies
Central nervous system
Ataxia
Brainstem dysfunction 
Hypotonia 
Pyramidal signs
Seizures, specially myoclonic-seizures 
Stroke-like episodes
Periferal nervous system and muscle
Motor,sensory and autonomic neuropathy 
Myopathy, exercise intolerance, weakness
Ocular system
Ophthalmoplegia, ptosis 
Optic atrofy 
Pigmentary retinopathy
Cardiovascular
Cardiac conduction defects 
Cardiomyopathy
Auditory system
Sensorineural hearing loss
Other systems
Endocrine dysfunction, i.e. diabetes mellitus 
Hepatic dysfunction
Renal dysfunction, i.e. proximal tubulopathy
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SYNDROMAL HEARING LOSS CAUSED BY MITOCHONDRIAL MUTATIONS.
The first mitochondrial mutations were detected in syndromes with pronounced neurological and 
ophthalmological manifestations such as the Kearns-Sayre syndrome, MELAS and MERRF 
syndrome. In approximately 70% of these multi-system disorders sensorineural hearing loss is 
present.10 A brief summary of the syndromes, mitochondrial mutations and the presence and 
incidence of hearing loss is given in table 2.
TABLE 2
Mt DNA-mutations with hearing loss as additional symptom in most common mitochondrial syndromes.
Clinical picture Hearing loss Mt-DNA-mutatie References
M ELA S:
Mitochondrial Encephalopathia 
nausea, vomiting 
migrainic stroke like episodes 
spongiosis gray matter
Hearing loss in 30% cases 
first or only symptom
Heteroplasmic point mutation Pavlakis11
in tRNA(leu)(uur) gene:A3243G
N ID D M
Non-insulin dependent diabetes Late onset
(3-4th decade of life) 
in 2-6 % Japanese diabetic 
individuals,
Heteroplasmic point mutation Ouweland12 ,Atawa13
in tRNA(leu)(uur) gene: A3243 G Katagiri14 Dawara15,
Alcolada 16 Vialettes 17Aitman18 
Oshima 19 , Yamasoba20
M E L A S
Mitochondrial Encephalopathia, 
lactic acidosis, stroke like 
episodes,diabetes, deafness
Hearing loss 
Unknown incidence
Heteroplasmic point mutation Goto 21 
in tRNA(leu)(uur) gene: T3271C
M E R F F
Myoclonic epilepsia 
red-ragged fibers,ataxia, 
dementia,opticus atrophy.
Hearing loss 
Unknown incidence
Heteroplasmic point mutation Shoffner22, Bercovic23,24 
tRNA(lys) gene: A8344G; A8356G Hammans25,Silvestri26 
Zeviani27
KSS
Kearns Sayre syndrome Hearing loss in 50% cases Large heteroplasmic duplications Zeviani28 
Progressive External and deletions in mt DNA 
Ophthalmoplegia
P earso n  syndrom e
Ptosis, retinopathy, cardiac 
conduction defects 
cerebellar syndrome 
white matter spongiosis
Hearing loss Large heteroplamic deletions and Poulton29 
unknown incidence duplications in mtDNA
Bilateral hearing loss, ataxia 
myoclonus; lactic acidosis; 
vestibular dysfunction
Variable onset of 
moderate to severe 
hearing loss
Heteroplasmic point mutation Tiranti30, Ensink31 
in tRNA(ser)(ucn) gene. Cins7472
Note: in all cases the hearing loss is sensorineural;post-lingual and progressive
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The A(adenosine) to G(guanosine) basepair substitution at nucleotide position 3243 of the tRNA 
(leu)(uur) gene was initially detected in the MELAS syndrome but this mutation is also responsible for a 
syndrome characterized by a late onset of hearing loss in the fourth decade of life mostly after onset 
of diabetes mellitus.11,12 This association of diabetes mellitus, high frequency hearing loss and a 
mitochondrial mutation was confirmed in several studies of diabetic patients.13-20 In Japan 2-6 % of 
diabetic patients harbor the A3243G mutation. In patients with diabetes and late onset hearing loss 
approximately 60% harbor this mutation.15 So far no extensive study has been performed that 
investigates the involvement of this mutation in adult onset of hearing loss. In other common 
mitochondrial syndromes eg. the MERRF and Kearns-Sayre syndrome sensorineural hearing loss is an 
additional symptom in approximately 50% of reported cases. In Pearsons syndrome ophthalmological 
manifestations are more pronounced but sensorineural hearing loss is also present.
An Italian-Sicilian family reported by Tiranti disclosed more audiological complaints as predominant 
symptom next to neurological and opthalmological complaints. The responsible mutation consist of an 
extra C(cytosine) nucleotide at position 7472 altering the tRNA(ser)(ucn) gene. A recently described 
Dutch family, harbored the same mutation. An identical neurological picture was found in the 
proband but in the majority of family-members hearing impairment was sole manifestation. 30,31 
These different findings, attributed to an identical mutation emphasizes the clinical heterogenity that 
is characteristic in these maternally inherited syndromes and confirms that more phenotypes can be 
adressed to a single mutation.
NON SYNDROMAL HEARING LOSS.
The first and untill now most frequently reported mitochondrial mutation reponsible for non- 
syndromal hearing loss was found in an isolated Arab-Israelic family with maternal inheritance of 
non-syndromal hearing loss.4 The deaf family members predominantly have profound to severe 
sensorineural hearing loss with onset during infancy. Additional studies of the family disclosed no 
vestibular anomalies.34 This family showed a point mutation consisting of a substitution of an 
adenosine(A) in guanosine(G) at position 1555 of an r-RNA gene.35 Consecutive families from Zaire 
and Spain were described confirming this
point mutation. In both families the majority disclosed congenital origin of hearing loss.36,37
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The second mutation responsible for non-syndromic hearing loss was described in families from 
Scotland and New-Zealand and consists of a C (Cytosine) to G replacement at position 7445 of the 
mitochondrial genome.38-40 Both families disclosed variable onset of hearing loss from the age 3-18 
years. Hearing loss was mild to severe and typically affected the higher frequencies. No vestibular 
dysfunction was found. In the family from New Zealand the penetrance was 100% eg. all children 
exhibited hearing loss. This was not found in the family from Scotland, where the penetrance was 
rather low (50%). Reduced penetrance is also present in the Arab-Israelic family and both families 
from Spain.
OTOTOXIC HEARING LOSS.
High levels of aminoglycosides are responsible for hearing loss. In developping countries the use of 
these ototoxic drugs is still high.32,33,36 Susceptibility to regular dosis of aminoglycosides and possible 
maternal inheritance was first suggested in 1989.32 A study on 36 additional Chinese families 
confirmed this idea.33 Several reports suggest a genetic component influencing the susceptiblity to 
normal dosis of aminoglycosides with variable penetrance. These individuals may harbor the A to G 
mutation at position 1555 in the mitochondrial genome. However in only 17% of unrelated American 
individuals with hearing loss after exposure of normal dosis of aminoglycosides the 1555 mutation 
was detected.41 The same mutation is also responsible for sensorineural hearing loss without the use of 
ototoxic drugs.4
PRESBYACUSIS.
Upon ageing the resulting loss of oxidative phosphorylation activity has been a speculative factor to 
explain presbyacusis. With ageing the amount of mitochondrial mutations in tissues, especially the 
substantia Nigra can increase significantly.42,43 An important role of mitochondrial DNA mutations in 
Parkinsons disease has been suggested several times. No detailed investigation of mitochondrial DNA 
changes in individals with or without presbyacusis has been performed, and requires more research. 
One study however reports on a 4977 basepair deletion in two out of three investigated individuals 
with presbyacusis.44 The basal turn of the cochlea is thought to be more susceptible to presbyacusis. 
The stria vascularis is full of mitochondria and propably high frequency hearing is a more energy 
demanding process reflecting more and frequent involvement of high frequency impairment in 
maternally inherited disorders.
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AUDIO-VESTIBULAR CHARACTERISTICS IN MATERNALLY INHERITED 
DISORDERS.
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So far, very few audiological characteristics have been described in mitochondrial inherited diseases. 
Only Elverland 45 reports on the audiological characteristics in 26 affected family-members; in the 
less affected cases hearing impairment was confined to only the cochlea. More affected cases 
disclosed cochlear as well as retro-cochlear characteristics. Most studies 30,31,38,40,45, including several 
case reports 46-48 report on early involvement of high frequency impairment. Low frequency 
impairment tends to start later. Although poorly documentated, variation in onset-age of hearing 
impairment seems to be an additional characterictic in many maternally inherited diseases. 30,31,38,45
COUNSELLING OF MATERNALLY INHERITED HEARING LOSS:
A CHALLENGE FOR THE FUTURE.
When presented with a family with possible maternally inherited hearing loss, we are at this moment 
confined to DNA based diagnostics by detection of mitochondrial mutations and genetic counselling. 
Prevention, for maternally related family members, can only be usefull whenever a relative presents 
with aminoglycoside induced deafness.
In case of a family with a clear maternal inheritance pattern of non-syndromal hearing impairment one 
should consider the A1555G and C7445G mutations to be present.
Late-onset hearing impairment with or without late-onset diabetes could be associated with the 
A3243G mutation. The degree of heteroplasmia and the variation in onset and severity of hearing 
impairment makes a proper counselling difficult. Recognition of maternal patterns of inheritance is 
difficult because an autosomal dominant pattern of inheritance cannot be excluded in small families. 
Statistical analysis of the presence of a maternally inherited disease can only be done in large 
families.
So far no preventive or therapeutic interventions are known. One of the possible therapeutic 
interventions might be to overcome the complex deficiancy in the mitochondrial inner-membrane by 
co-factor substitution. This has been done by adding high dosis of riboflavins or Co-enzyme Q. In 
neurology this is nowadays an optional treatment.49 Investigating the pathogenic role of mitochondrial 
DNA in presbyacusis should be an aim for the future. The few temporal bone studies do not justify 
conclusions.50
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CONCLUSIONS.
Identification of mitochondrial involvement in genetic hearing loss has been an important 
achievement in the field of the genetics of hearing impairment. The small size of the mitochondrial 
genome facilitates the detection of the responsible mutations. The pathogenic pathway how an 
impaired energy metabolism can cause syndromal and non-syndromal hearing loss still needs further 
investigation.
However, genetic counselling in maternally inherited diseases has many limitations mainly due to the 
broad spectrum of clinical symptoms. Also small famillies make recognition of a maternally inherited 
pattern difficult.
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ABSTRACT.
We report on a three generation family with maternal inheritance of hearing loss. All maternally 
related family members (n=69) carried an extra C at position 7472 of the mitochondrial genome. 
Hearing loss was the only or presenting symptom in most family members and most pronounced at the 
higher frequencies. Lower frequencies became involved form the age of 10 years onward. In the 
majority vestibular hyperreactivity was present suggesting vestibulocerebellar dysfunction. Incidence 
of neurological complaints was low and complaints presented late. Numerous enlarged mitochondria 
were found in the proband and his neurologically unaffected younger brother. The muscle respiratory 
chain complexes showed marked reduction in complex I as well as in complex IV.
Respiratory chain dysfunction should be considered as a possible cause of progressive sensorineural 
hearing loss (SNHL). More research into the causes of high frequency impairment should be 
considered especially when SNHL , syndromal or non-syndromal is exclusively maternally 
transmitted. Maternally transmission of hearing impairment can be of additional value in unclear 
neurological syndromes.
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INTRODUCTION.
In recent years SNHL has been recognized as one of the symptoms or even the only abnormal feature 
in maternally inherited disorders.
Most inherited mitochondrial disorders preferentially come to expression in tissues with high energy 
requirements such as nerves and muscles. Neurological and ophthalmological manifestations are the 
prominant features.1-4 Also the cochlea is highly depending on respiratory chain metabolism. The 
estimated prevalence of SNHL in these multisystem disorders is approximately 70%.5 
Mitochondrial DNA (mtDNA) differs in many aspects from nuclear DNA. The mtDNA is small; it 
contains 16569 basepairs in a closed circular molecule and is inherited exclusively via the ovum. In 
most inherited mtDNA diseases individuals carry two distinct types of mtDNA, a condition that is 
known as heteroplasmy. Phenotypic expression depends on the proportion of transmitted mutant 
mtDNA and the energy requirement of the tissue. The nuclear DNA has a major role in mitochondrial 
metabolism, as it codes for the majority of the more than 70 distinct polypeptides involved in the 
respiratory chain. Involvement of nuclear genes in mitochondrial diseases have already been 
demonstrated.6,7
High-frequency hearing loss in combination with diabetes mellitus type II associated with the 
mitochondrial A3243G mutation. 8 Tiranti et al. reported on a maternally inherited disorder with 
SNHL as the first and most consistent symptom; in some family members, SNHL was the only 
manifestation of the disease.9 Ataxia, dysarthria and focal myoclonus were present in a more 
advanced stage of the disease.
SNHL with variable age of onset as the only manifestation of disease caused by the mitochondrial 
T7445C mutation was recently reported in two different families. 10,11
The mutation responsible for susceptibility to aminoglycosides (12S rRNA-A1555G) was later 
detected in an isolated family that showed maternal transmission of deafness. 12-14 
We report on a new, large, three-generation Dutch family with progressive SNHL as the sole or 
predominant feature. All maternally related members carried the 7472ins C muta­
tion. In many family members hearing loss was assessed with by serial audiometry. At a more 
advanced age, neurological signs and symptoms developed in the proband fairly similar to those 
reported in mitochondrial encephalomyopathies.5
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PATIENTS AND METHODS
Medical history was taken with special attention to hearing loss, neurological symptoms, visual 
impairment, diabetes mellitus and ototoxicity. A general otological examination, pure tone audiometry 
and analysis of previous audiograms were performed. In selected cases neurological and 
ophthalmological examination were performed.
Pure tone audiograms were obtained in a sound treated room with an Interacoustic AC 40 audiometer 
calibrated to ISO 389 according to the ISO 8253-1 standard.15 Air and bone conduction thresholds 
were measured in dB hearing level (HL). The method of ISO 7029 was followed to calculate the P95 
(95 th percentile) threshold values for presbyacusis for each patient at each frequency.16 Two 
individuals (III3  and III9 ) were investigated at their home using a portable audiometer (Madsen DSA 
84). We measured some selected partners to exclude the possibility of genetic transmission of 
deafness from a different family.
Vestibular examination was performed in individuals with a high Fletcher index (i.e. average 
threshold in dB at 1000-2000-4000 Hz) of more than 25 dB. All of them were questioned specifically 
about any symptoms of dizziness or motion sickness. Vestibular tests were performed in the dark with 
the eyes open. Eye movements were recorded by means of direct-current (DC) electro-oculography. 
Gaze positions were tested to see if there was any gaze-evoked nystagmus. Saccade metrics were 
evaluated for 200 calibration saccades. Smooth pursuit was tested with a sinusoidal stimulus (200/s 
peak velocity). Optokinetic nystagmus was elicited with shadow bands (width and separation 7.50) 
projected onto a hemicylindrical screen (90x110°) at constant velocities of 40 and 600/s. The 
vestibulo-ocular reflex (VOR) was tested with 900/s velocity steps using a rotary chair and with 
caloric stimulation. The cervico-ocular reflex was tested in one case of vestibular areflexia by 
sinusoidal body rotation under the head which was fixed in space (in the dark, with open eyes) at a 
frequency of 0.1 Hz and an amplitude of 300. Methods, results and computer analysis have been 
previously described.17,18
Blood samples were taken for DNA extraction. Large rearrangements in mitochondrial DNA were 
studied by southern blot analysis. Because hearing loss was the main clinical symptom in all family 
members the T7445C; A1555G and Cins7472 mutations were investigated. The T7445C mutation was 
analyzed as described by Reid.10 The A1555G mutation was analyzed by testing for the loss of a 
Bsma I restriction site in a PCR
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product encompassing the 1555 nucleotide region.1 * Modified PCR amplication followed 
by digestion with Xcm i was used to analyze the Cins 7472 m utation in the tRNA Ser<uc,,) 
gene. An insertion at position 7472 can so be easily detected since this modified PCR 
primer creates an artificial site in the PCR product/'
A quadriceps muscle specimen in the proband (IIIi0) obtained at the age of 68 years was 
processed for histochemistry and biochemistry. The oxidation rates for pyruvate and 
malate and the production of A TP+ creatinine phosphate of the intact mitochondria in a 
supernatant of the fresh muscle were determinated. Activities of enzyme complexes of the 
respiratory chain and pyruvate dehydrogenase complex were measured in the supernatant 
from fresh muscle according to Fischer et al, 19
Figure 1.
Pedigree o f three generations with maternally transmitted deafness. Squares represent males. Black circles affected females. 
Gray squres and circles represent carriers of the mutation without disease manifestation. * Symbolizes the proband
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RESULTS.
Clinical study of family: All born to the deaf great-grand mother (II1) were audiometrically assessed. 
The pedigree with a total of 105 living individuals demonstrates a maternal trait of deafness present in 
9 different sibships.(Figure 1)
Two children (III1 and III7 ) experienced a drop in hearing by history in the first week of their 
treatment with dihydrostreptomycin for tuberculous spondylitis. A similar drop, of 50 dB, which 
could be evaluated audiometrically, occurred in a cousin (IV2 5 ) at 4 years.
Index case: The proband (III10) suffered from progressive bilateral hearing impairment with tinnitus 
and dizziness since the age of 18 years. Latest examination, at the age of 68 years, revealed a hearing 
loss of 84 dB hFI that was most pronounced at the higher frequencies. Other complaints compromise 
angina pectoris; impaired renal function probably due to late onset diabetes mellitus with serum 
creatinine of 203 mmol/l (normal < 60-110 mmol/l ) and serum urea of 16.7 mmol/l (normal <3-7 
mmol/l).
Neurological examination: Examination of the proband revealed an ataxic gait, severe dysarthria, 
truncal and limb ataxia, dysdiadochokinesis and motor and sensory polyneuropathy in both arms and 
legs. Excercise tolerance had decreased severely from the age of 40 years when neurological 
symptoms developed. Recent MRI examination of the brain showed advanced atrophy of the superior 
cerebellar vermis and multiple subcortical white-matter lesions in the semi-oval centre. Serum 
myoglobin concentration was slightly elevated with 108ug (n<100ug). Creatinekinase (CK) was 
normal. Neurological examination of a younger brother (III12) was normal. An older brother (III5) had 
died within one year of an unspecified rapidly progressive neurological disease which had been 
diagnosed as possible amyotrophic lateral sclerosis. Other family members had no history of 
neurological signs or symptoms. Various psychiatric disorders, such as paranoid schizophrenia, 
psychosis and depression had occurred over a long period in the great-grandmother and some of her 
children.
Ophthalmological examination: No tapetoretinal degenerations were found in four individuals 
examined (III10 ,IV26,31,49 ); however in all lenses were less clear than was expected for their age. Non­
insulin dependent hyperglycemia had caused the cotton-wool
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lesions of diabetic retinopathy in the index case. Two sisters (III3 ,III19) are being treated for insulin 
dependent hyperglycemia that started at the age of about 45 years.
Figure 2.
Ultrastructure of striated muscle in individual III10 (A: m. soleus ) and 
individual III12 (B: m. quadriceps). Note the enlarged mitochondria with para-crystalline inclusions and parking 
lot arrangements ( large arrows). Small arrows point to normal mitochondria. (Bar represent 1 um )
Muscle biopsies: Light microscopical examination was normal. Ultrastructural examination revealed 
numerous enlarged mitochondria with paracrystalline inclusions in the proband (III10) and his brother 
(III12).(Fig 2) The muscle respiratory chain enzyme complexes in the proband showed marked 
reduction in both complex I; 7,2 (n=24-87) and COX (complex IV); 19 (n=68-347).
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Hearing: Audiometry in 32 out of 69 individuals demonstrated a significantly increased hearing 
threshold as related to the P95 (95 th percentile) presbyacusis values. Individuals 
IV41 , not a maternal relative, and IV4 4  both suffered from noise trauma.
Five family members whose previous audiograms had been obtained from elsewhere showed 
progressive high frequency hearing impairment. All had a negative history for acquired causes of 
hearing impairment. Two subjects (III3 and III8) were excluded from analysis because they only 
showed presbyacusis.
Regression analysis of serial audiograms seemed to suggest that high frequency impairment (4-8 kHz) 
may have been present already at birth or in early childhood, however hearing impairment at the 
lower frequencies (0.25 - 2 kHz) occurred in some individuals below 10 years of age and was nearly 
always present below the age of 20 years. The average annual threshold increase (ATI) was in the 
range of 0.8-1.5 dB/yr at all frequencies (Figure 3). Analysis of longitudinal data from 11 individuals 
confirmed that at a given age high frequency impairment was more severe than low frequency 
impairment. However, instead of confirming the presence of congenital impairment, this analysis 
indicated onset of hearing impairment in the first or second decade of life. (Figure 4) Progression 
seemed to be nonlineair, ie. with more rapid progression in the initial stage of the disease.
Vestibulo-ocular system: Vestibulo-ocular functions were evaluated in 20 out of 32 affected persons. 
Optokinetic nystagmus responses were normal in all, except for the proband (III10) who showed 
response deterioration at 600/s stimulation. Five patients, all without any vertigo or dizziness, had 
normal vestibular responses. One (IV25) showed vestibular areflexia with an enhanced cervico-ocular 
reflex which was attributed to previous treatment with streptomycin. Thirteen patients exhibited 
vestibular hyperactivity; three (III19; IV19,23) with dizziness and 2 (IV911) had special susceptibility to 
motion sickness.
Three of the patients with a hyperactive VOR( III19 ; IV19,23) made an extremely nervous impression 
during their examination; two ( IV19 23) had the hyperventilation syndrome. One additional patient 
(V2 4 ) with motion sickness susceptibility, whose VOR was normal except for significant asymmetry, 
showed significant unilateral caloric hyporeflexia.
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Figure 3. (top) Regression analysis o f the most recent audiogram in 28 family members with maternally inherited SNHL. 
The intercept o f about 15 dB at 4-8 kHz seems to suggest the possibility o f congenital hearing impairment. The 
intercept o f about 8 years at 0.25- 2 kHz suggests postnatal onset o f hearing impairment.
Figure ^.(bottom) Trend analysis o f serial audiograms in 11 individuals with sufficient audiological data. Especially 
observations at the lower frequencies (left panel) suggests the possibility o f post natal onset and initial non-linear 
progression o f hearing impairment.
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MUTATIONAL ANALYSIS.
Southern blot analysis of the Dutch family revealed no large rearrangements. PCR amplification and 
restriction enzyme analysis excluded the presence of the T7445C and A1555G mutations. However 
in all maternally related relatives, we found the insertion of an extra C at nucleotide position 7472 in 
the tRNA(Ser)(UCN) gene. This mutation was not present in 100 normal control persons. Because the 
normal mt PCR product remained visible after restriction enzyme analysis, in almost all family 
members, heteroplasmy was confirmed. Sequence analysis of the PCR fragment containing the 
Cins7472 mutation confirmed the presence of a seventh cytosine at nucleotide positions 7472.
No correlation was found between the high Fletcher index; age and degree of heteroplasmy. The 
percentage of heteroplasmy varied between family members from 26% (V24 ) to 99% (nIi2 ,i9 , 
IVi,7 ,2 5 ,3i). In the majority of hearing impaired individuals (> 90%) heteroplasmy varied between 80 to 
i00%. It seemed that the widest range of heteroplasmy was present in the youngest least affected 
individuals.
DISCUSSION.
Disorders with mitochondrial inheritance are characterized by a progressive course and a broad 
spectrum of abnormalities. Most mutations occur in highly conserved t-RNA genes; homoplasmic 
mutations present in infancy and generally manifest themselves as fatal pediatric diseases.5 Only two 
mutations in the mitochondrial genome; the Ai555G and T7445C mutations, are reported in 
association with non-syndromic hereditary deafness.1011 In two unrelated families with the T7445C 
mutation, penetrance of deafness varied considerably. Enviromental factors, heteroplasmy and the 
presence of a second nuclear locus have been suggested to explain this phenomenon.10-12 The C 
insertion that was present in asymptomatic carriers should give reason for considering an additional 
cause of hearing loss. The T7445C mutation is situated in the same t-RNA gene as the 7472 ins C 
mutation, however it causes a different disorder. The susceptibility to aminoglycosides, i.e. with a 
remarkable drop in hearing ability in three individuals, initially raised our suspicion of the A1555G 
mutation.
The present analysis of hearing loss in our family shows the existence of a similar progression at all 
frequencies as was previously described in another family showing
maternal inheritance.20 However, in our family hearing impairment started earlier and was more 
pronounced at a young age at the higher frequencies.
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Early, predominant involvement of the high frequencies was reported previously, 8,21,22 but no report 
suggested a congenital component, as we were inclined to do only on the basis of the analysis of the 
most recent audiograms. However, longitudinal analysis of hearing impairment data disclosed non­
linear progression, with onset of hearing impairment in the first or second decade and presumably 
more rapid progression in the initial stage of the disease.
Analysis of hearing impairment is obviously needed in the youngest individuals at risk to evaluate the 
early condition and course of hearing impairment. Observation of the higher frequencies (8-18 kHz) 
by Elverland suggests detection of high frequency impairment in very young children at risk.20 
The proband's optokinetic response detoriation with sustained stimulation at 600/s can be interpreted 
as another type of excercise fatigue. The major vestibular finding in this study was the high 
prevalence of vestibular hyperactivity (VH) in 13 out of 20 hearing impaired individuals. Dizziness or 
motion sickness susceptibility was an associated finding in 3 out of the 13 VH cases, whereas there 
was one additional case of motion sickness susceptibility without VH but with unilateral caloric 
hyporeflexia and asymmetry of the VOR.
VH has been described in multiple sclerosis, vestibulocerebellar dysfunction and in the 
hyperventilation syndrome and also in association with vestibulocerebellar dysfunction in children 
with congenital hyperbilirubinaemia. The latter finding illustrates the vulnerability of the 
vestibulocerebellum to metabolic disturbances, presumably owing to the high energy requirements. In 
the Gunn rat, Purkinje cells that are inhibitory to vestibular nuclear neurons are damaged by 
congenital hyperbilirubinaemia.23
The prevalence of neurological abnormalities seems low among hearing impaired individuals. 
However, the index case exhibited characteristics of a mitochondrial encephalopathy, as probably did 
his deceased brother (III5 ). Another hearing impaired younger brother displayed a muscle biopsy with 
enlarged mitochondria and paracrystalline inclusions. Some depressive disorders have been found 
among members of a family with multiple deletions of mtDNA.24
The Cins 7472 mutation was first detected in a small Sicilian family with hearing impairment as the 
earliest and most prominent feature; neurological symptoms occurred more and presented earlier; 
focal myoclonus was characteristic. 9
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Both index cases had striking atrophy of the superior cerebellar vermis and they showed similar light 
microscopical and ultrastructural findings in their muscle biopsies. Subcortical white matter lesions 
were not described before.
Mitochondrial inheritance is a possible explanation for a higher prevalence of affected mothers in 
diabetic individuals. The A3243G mutation was detected in association with SNHL as well as DM. 
DM usually appears before SNHL but may also present in the third or fourth decade of life.8 It may 
be that the insertion of an extra C predisposes to late-onset IDDM, as was observed in our family, but 
this needs further investigation.
Individuals with a respiratory chain disease usually present with such a wide variety of signs and 
symptoms that it may seem almost impossible to establish a syndromal diagnosis. It appears that 
presence of hearing impairment, ocular myopathy and maternal inheritance are most helpful in 
establishing the diagnosis.25
Identification of the mitochondrial nature of the neurological disorder in the proband occurred only 
after the evaluation of the maternal inheritance pattern of hearing impairment. These identifications 
are particulary relevant to genetic counselling, although heteroplasmy can make proper counselling 
very difficult.
REFERENCES.
1. Pavlakis SG, Phillips PC, Dimauro S et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike 
episodes: a distinctive clinical syndrome. Ann Neurol 1984; 16, 481-488.
2. Shoffner JM, Lott MT, Lezza AMS et al. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated 
with a mitochondrial DNA t RNAlys mutation. Cell 1990; 61, 931-937.
3. Degoul F, Nelson I, Lestienne P, et al. Deletions of mitochondrial DNA in Kearns Sayre and ocular myopathy; 
genetic , biochemical and morfological studies J. Neurol Sci. 1991;101, 168-177.
4. DiMauro S, Bonilla E, Zeviani M et al. Mitochondrial myopathies. Ann Neurol 1985; 17, 521-538.
5. Gold M, Rapin I. Non-Mendelian mitochondrial inheritance as a cause of progressive sensorineural hearing loss. Int J 
Pediatr Otorhinolaryngol. 1994; 30, 91-104.
6. Zeviani M, Bresolin N, Gellera C, et al. Nucleus-driven multiple large scale deletions of the mitochondrial genome: a 
new autosomal dominant disease. Am J Hum Genet 1990; 47, 904-914.
7. Cormier P, Rotig A, Tardieu M et al. Autosomal dominant deletions of mitochondrial genome in a case of 
progressive encephalomyopathy. Am J Hum Genet 1991; 48, 643-648.
8. Van den Ouweland JM, Lemkes HHP et al. Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with 
maternally transmitted type II diabetes mellitus and deafness. Nature Genet. 1992;1,368-371.
9. Tiranti V, Chariot P, Carella F et al. Maternally inherited hearing loss, ataxia and myoclonus associated with a novel 
point mutation in mitochondrial tRNA-ser (UCN) gene. Hum Mol Genet 1995;4,1421-1427.
10. Vemham GA, Reid FM, Rundle PA et al. Bilateral sensorineural hearing loss in members of a maternal lineage with 
a mitochondrial point mutation.Clin Otolaryngol 1994;19,314-319.
11. Fischel-Ghodsian N, Prezant TR, Fournier P et al. Mitochondrial mutation associated with non-syndromic deafness.
51
Am J Otolaryngol 1995;16,403-406.
12. Jaber L, Shohat M, Bo X et al. Sensorineural deafness inherited as a tissue specific mitochondrial defect. J Med 
Genet 1992; 29, 86-90.
13. Prezant TR, Agapian JV, Bohlman C et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic- 
induced and non-syndromic deafness. Nature Genet 1993; 4, 289-294.
14. Hu D, Qiu WQ, Wu BT et al. Genetic aspects of antibiotic induced deafness: mitochondrial inheritance. J Med Genet 
1991; 28, 79-83.
15. International Organization for Standardization. ISO 8253-1: Acoustics: Audiometric Test Methods, I: Basic Pure 
Tone Air and Bone conduction Threshold Audiometry. Geneva Switserland, International Organization for 
Standardization, 1989.
16. International Organisation for Standardization. ISO 7029. Acoustics: Threshold of hearing by air conduction as a 
function of age and sex for otologically normal persons. Geneva Switserland, International Organization for 
Standardization,1984.
17. Huygen PLM. Nystagmometry. The art of measuring nystagmus parameters by digital signal processing. ORL J 
Otorhinolaryngol Relat Spec 1979;41, 206-220.
18. Huygen PLM. Vestibular hyperreactivity in patients with multiple sclerosis. Otorhinolaryngol 1993;30,141-149.
19. Fischer JC, Ruitenbeek W, Gabreels FJM. A mitochondrial encephalomyopathy. The first case with an established 
defect at the level of co-enzyme Q. Eur J Pediatr 1986;144, 441-444.
20. Elverland HH, Torbergsen T. Audiological findings in a family with mitochondrial disorder. Am J Otol 1991;6, 459­
465.
21. Swift AC, Singh SD. Hearing impairment in the Kearns-Sayre syndrome. J. Laryngol. Otol. 1988;102,636-627.
22. Donovan TJ. Mitochondrial Encephalomyopathy: A rare genetic cause of sensorineural hearing loss. Ann Otol 
Rhinol Laryngol. 1995;104,786-792
23. Schutta HS, Johnson L. Encephalopathy in the Gunn rat. A fine structure of the cerebellar cortex. J Neuropathol. Exp 
Neurol 1967;26,377-396.
24. Suomalainen A, Majander A, Haitia M et al. Multiple deletions of mitochondrial DNA in several tissues of a patient 
with severe retardet deperssion and familial progressive external ophthalmoplegia. J Clin. Invest 1992;90,61-66
25. Jackson MJ . schaeffer JA, johnson MA et al. Presentation and clinical investigation of mitochondrial respiratory 
chain disease. A study of 51 patients. Brain 1995; 118, 339-357
5 2
Chapter
2c
Comparison of probands
A mitochondrial point mutation at 
position 7472 causes early onset hearing loss 
and late onset neurological symtoms.
Report of a Dutch family and comparison 
with a Sicilian family.
RJH. Ensink 
PLM. Huygen 
HAM. Marres 
K. Verhoeven 
G. van Camp 
GW. Padberg 
CW. Cremers
Proceedings 2nd Workshop Genetics on Hearing Impairment Milan okt 96 
Book of Abstracts, chapter 21, pp 116-120. Whurr Publishers, London 1998
5 3
54
Chapter 2
INTRODUCTION.
Many neurological previously unclassified syndromes have been linked to mitochondrial mutations 
over the past few years. 1 The mitochondrial DNA has emerged as the best studied DNA in humans. 
The small size o f the DNA (16659 basepairs ) accounts for this.
In general deletions, duplications and point mutations are the most commonly present mutations.2 
Large-scale rearrangements have a clinical picture compatible with ocular myopathy; most common is 
the Kearns-Sayre syndrome with or without characteristics o f chronic progressive ophthalmoplegia 
(CPEO). Point mutations are mainly maternally inherited with nowadays distinct inherited syndromes 
as LHON, MERRF and MELAS syndrome. 1
In approximately 70% of these maternally inherited syndromes hearing impairment is an associated 
finding.3
Two mitochondrial mutations have been associated with hearing loss as the only symptom of disease. 
The first detected mutation consists o f a A1555G substitution in the 12S r-RNA gene and is also 
associated with aminoglycoside induced deafness. 4 The second, a C7445G substitution in the tRNA 
ser(ucn) gene, has been detected in two unrelated familiy's originating from New Zealand and Scotland 
respectively.5
We found a third, large Dutch, family with a maternal trait o f hearing impairment with full penetrance 
and additional, mainly late onset, neurological signs and symptoms in the proband only. This mutation 
was previously described in a family originating from Sicily. 6 We describe and compare both families 
and their probands.
COMPARING THE DUTCH AND SICILIAN FAMILIES AND THEIR PROBANDS WITH  
THE 7472 MUTATION.
Dutch family
The pedigree o f the Dutch family consists o f 69 maternally related family members. High-frequency 
impairment was the only presenting symptom in 29 out o f 32 (91%) family members. Similar to the 
index case hearing deteriorated from the age o f approximately 2 0  years; although some relatives 
reported an onset-age o f 45 years. Tinnitus and vertigo problems that gradually became worse were 
present in the proband since the age o f 18 years. Many family members have developped similar 
complaints. Vestibular dysfunction was demonstrated in the majority o f the family-members. (13/20) 
One brother died from a progressive previously unclassified syndrome believed to be some type of 
amyothrofic
lateral sclerosis which started at the age o f 40 years. In another brother, focal myoclonus was 
reported. The proband exhibited similar neurological complaints consisting o f dyarthria, truncal ataxia
55
and distal polyneuropathy from the age o f 30 years as was also present in his deceased brother. No 
focal myoclonus was observed. No other family members exhibited clear neurological complaints. To 
evaluate neuromuscular complaints, muscle biopsy was performed which revealed numerous altered 
mitochondria with para-crystalline inclusions and lipid accumulation. The superior cerebellar vermis 
appeared atrophfic om MRI. (Figure 1)
Figure 1.
Characteristic abnormalities found in the Dutch proband also found in the Sicilian proband. Atrofy found in the superior 
cerebellar vermis. (*)
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Sicilian family
The pedigree o f the previously reported Sicilian family consists o f 20 maternally related family 
members. 1 (Figure 2)
0% 71%
Figure 2.
Pedigree o f Sicilian family with the same mitochondrial mutation. Dotted figures only hearing loss; % intermediate clinical 
picture; black : full blown neurological picture. Percentage o f heteroplasmia indicated.
Only in three individuals hearing loss was the only manifestation. Although not specified, hearing 
impairment was presenting symptom in the majority o f the neurologically affected individuals. 
Hearing loss generally started at a young age, ranging from 15-28 years and was often accompanied 
by tinnitus and "episodes o f vertigo". Neurological complaints were more marked and presented 
earlier. Characteristic complaints were focal myoclonus, dysarthria, gait ataxia and mild generalized 
hypotonia with dysesthesia. No data on vestibular functions were available. A niece o f the proband 
suffered at the age o f 25 from a neurological syndrome characterized by optic neuritis, ataxia and 
diplopia and moderate mental detoriation without tinnitus and normal hearing without episodes of 
vertigo.
The proband presented with focal myoclonic jerks o f the abdominal muscles at the age o f 28 years; 
over the past 3 years he experienced hearing impairment and tinnitus. Brainstem evoked potentials 
disclosed cochlear and retro-cochlear characteristics. Muscle biopsy
disclosed altered mitochondria with altered christae and para-crystalline inclusions. Atrophy o f the 
superior cerebellar vermis was found on CT and MRI examination.
Table 1 compares both probands and their families.
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Table 1: Comparison ofthe Dutch and Sicilian probands
Dutch proband Sicilian proband
Age at examination (yrs) 6 8 35
Hearing impairment (onset) 18 yrs 25 yrs
Average hearing loss (hFI) 6 8  dB 45 dB
Tinnitus + +
Focal myoclonic jerks Absent +
Ataxic gait + +
Dysarthria + +
Truncal ataxia + Absent
Dysaesthesia lower limbs + +
Eyes optic fundi Normal Normal
Eyes cataract Present Not examined
ECG Cardiac conduction defect Normal
Renal function High levels urea, creatinin Not investigated
Muscle biopsy Altered large mitochondria, 
abundant intra-muscular fat
Large mitochondria 
cristalline cristae
Red-ragged fibers Absent Absent
Maternal great grand-mother No consanguinity Consanguineous marriage
Hearing impairment Starting high frequencies Starting high frequencies
Hearing impairment/ family Initial and only Initial manifestation
Neurological symptoms in 
Family
Infrequent More prominent 
Early onset
CONCLUSION.
Many similarities were found comparing the two families with the extra C insertion at position 7472 
of the mitochondrial tRNA ser(ucn)gene. Especially both probands had
remarkable similarities in their clinical picture. Their families differ especially in the degree of 
hearing impairment and the onset age o f neurological symptoms.
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DISCUSSION.
Maternal inherited hearing impairment may prompt to the detection of a mitochondrial mutation in a 
family where the proband presents with an unclear and undefined neurological syndrome. Further 
research will show whether the prevalence o f mitochondrial hearing impairment is higher than 
presently recognized. It will also clear whether genuine non-syndromic types o f mitochondrial hearing 
impairment exist or as might be expected, oligosymptomatic types with hearing impairment as the
most prominent and/or the earliest abnormality occur more frequently.
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ABSTRACT.
We studied a large Dutch family with maternally inherited, progressive, sensorineural hearing loss in 
27 patients. Only in a single family member, the hearing loss was accompanied by neurological 
symptoms including ataxia and dysarthria. DNA analysis o f the mitochondrial genome revealed the 
insertion o f a C at nucleotide position 7472 in the t-RNASer(UCN) gene (7472insC mutation). We 
determined the percentage o f mutant DNA (heteroplasmy) in blood from all family members, and 
found no correlation between hearing loss and leucocyte heteroplasmy. The 7472insC mutation was 
previously identified in a smaller family from Sicily with sensorineural hearing loss in 13 family 
members, 7 o f them also showing a neurological picture with ataxia and myoclonus. The presence of 
the 7472insC mutation in two different pedigrees strongly supports its pathogenicity. However, the 
interfamilial difference in penetrance o f the neurologic abnormalities is most likely strongly 
influenced by secondary factors different from the 7472insC mutation as heteroplasmy or age o f the 
patients were similar in both families. This mutation should therefore be analyzed in families with 
maternally inherited hearing loss, irrespective whether the hearing loss is non-syndromic or 
accompanied by neurologic abnormalities.
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INTRODUCTION.
Several human tissues and organs like the brain, retina, muscle, kidney and endocrine glands are 
highly dependent on the energy produced by mitochondrial oxidation. As a consequence these tissues 
are more vulnerable to mitochondrial defects. 1’2 In almost all mitochondrial diseases identified so far 
one or more o f these tissues or organs is involved. In many of these hearing loss is an accompanying 
symptom. This is probably caused by a high reliance o f the inner ear on mitochondrial energy 
production.3 Until now only three different mutations in the mitochondrial genome have been reported 
to cause hearing loss as a sole or predominant symptom. The first mutation, an A to G substitution at 
position 1555 in the 12S rRNA gene (1555A^G ), was reported in a large Israeli-Arab family with 
maternally inherited, non-syndromic hearing loss .3 This mutation was also found in many other 
pedigrees with non-syndromic deafness4-6, and in patients with aminoglycoside induced ototoxic 
hearing impairment.4,7-9 Apparently this mutation makes individuals susceptible to hearing 
impairment after treatment with aminoglycosides at concentrations that normally don’t affect hearing. 
Even without exposure to aminoglycosides many patients with this mutation develop hearing 
impairment, but it is currently unknown which other factors are involved. A second mutation of the 
mitochondrial genome was described in a Scottish family with maternally inherited, bilateral, 
sensorineural hearing loss .10 The mutation substituted a G for an A at position 7445 (7445A^G ) of 
the mtDNA and has subsequently been observed in a second pedigree from New Zealand. 11 
The insertion o f a C at nucleotide position 7472 in the tRNASer(UCN) gene (7472insC) has been 
reported in a Sicilian family with maternally inherited hearing loss as a predominant feature. 12 In 7 out 
of 13 patients the hearing loss was accompanied by ataxia, dysarthria and focal myoclonus. In this 
study we report a second family with the 7472insC mutation. Although neurological abnormalities 
were found in only a single patient o f this large family, no significant difference in heteroplasmy was 
found between this family and the first family from Sicily, in which 7 patients have neurological 
problems. These results indicate that the strongly reduced penetrance o f neurological symptoms in 
this family is most likely caused by other factors besides the 7472 ins C mutation.
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Figure 1.
Pedigree of the Dutch family members. Family members from whom a DNA sample was available are numbered. In all family members of 
the maternal line the presence of the 7472insC mutation was demonstrated. The age of the living family members and the percentage of 
mutant mitochondrial DNA are indicated below the symbol. Patients with hearing loss only are indicated by a half-filled symbol.
Patients with hearing loss and diabetes mellitus type II are indicated by a three-quarter filled symbol.
The patient with hearing loss, diabetes mellitus and neurological symptoms is indicated by a solid symbol (arrow)
Unaffected family members are indicated with open symbols. Individual II-30 had hearing loss caused by noise exposure, and was 
therefore given an unknown affection status.
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PATIENTS AND METHODS.
Audiometric studies: Sixty-four family members including 10 spouses participated in this study 
(Figure 1 ). A general otological examination and pure tone audiometry with air and bone conduction 
was performed. Pure tone average hearing thresholds at 0.25, 0.5, 1, 2, 4 and 8  kHz were determined. 
Patients with a hearing threshold below the 95th percentile o f an age and sex dependent audiometric 
curve (ISO) were considered hearing-impaired. Family members with a hearing threshold better than 
20 dB or above the 50th percentile were considered normal hearing.
Twenty-seven family members were found to be hearing impaired. Their hearing loss was 
accompanied by tinnitus in the majority o f patients, and by dizziness in about 1/3 o f patients. Two 
family members (I:1 and II: 16) showed a documented acute drop in their hearing levels after treatment 
with streptomycin for tuberculous spondylitis and pneumonia, respectively. A third family member 
from the maternal line (who did not participate in this study) had hetero-anamnestically an acute loss 
of hearing after 2 weeks o f treatment with streptomycin for tuberculous pneumonia. One patient with 
hearing loss (II:30) had a history o f noise exposure and was therefore given an unknown affection 
status.
In all patients, hearing loss was sensorineural and progressive, mainly affecting the high frequencies 
in the initial stage and gradually affecting lower frequencies with increasing age. Hearing loss was 
first noted in the patients between 12 and 45 years o f age. Nearly all family members from the 
maternal line older than 30 were affected, except for 4 family members, between 38 and 47 years old 
(II-3, II-6 , II-24, II-26).
Clinical examination : All family members were interviewed about their clinical history, and the 
presence o f possible neurological complaints was investigated by questionnaire. Nine different family 
members o f the maternal line were selected for a neurological examination. Eight family members 
ranging in age from 35 to 55 had no neurological abnormalities, but most o f them showed a mild 
neurological picture which can best be described as clumsiness. Only the proband (patient I-5) had 
truncal and limb ataxia, dysarthria and motor and sensory polyneuropathy in the limbs.
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MRI o f the probands brain showed atrophy o f the cerebellar vermis and multiple subcortical white 
matter lesions. Two deceased brothers o f the proband had suffered from a neurological picture similar 
to that o f the proband. However, no clinical data could be recovered from these deceased patients. 
Ophthalmological examination o f four patients showed no evidence o f tapetoretinal degeneration. 
Three patients (I-4, I-5, I-13) reported diabetes mellitus type II.
MtDNA mutation analysis: Blood samples were taken after informed consent. Total DNA was 
extracted from blood samples by standard techniques. To detect large mitochondrial rearrangements, 
Southern blot analysis was performed. The presence o f the 7445A ^G  and 1555A^G  mutations 
associated with hearing loss, were investigated.3,10 Analysis o f the 7472insC mutation in the 
tRNASer(UCN) gene was done by modified PCR amplification followed by digestion with XcmI, as 
previously described. 12 In order to determine the percentage o f mutant mtDNA, Solid Phase Mini 
Sequencing (SPMS) analysis was carried out as described previously. 12 DNA sequencing of the PCR 
fragment containing the 7472insC mutation was performed on a Perkin-Elmer automated DNA 
sequencer using dye-primer cycle sequencing kits (PE).
Statistical analysis: We wished to find out whether there was a significant correlation between the 
percentage o f mutant mtDNA and the hearing loss. Because the percentage o f mutant mtDNA clearly 
was not normally distributed, we used nonparametric statistics. Spearman’s rank correlation test was 
used to evaluate the correlation and the Mann-Whitney test was used for comparing differences in 
heteroplasmy between groups o f patients with different symptoms and signs. The level o f significance 
used was P= 0.05 in all tests.
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RESULTS.
MtDNA mutation analysis: As the hearing loss was inherited maternally, a mitochondrial inheritance 
was assumed and mutation analysis o f the mtDNA was performed. Southern blot analysis o f 5 patients 
revealed no large mtDNA rearrangements. Three different mitochondrial point mutations have been 
reported in association with hearing loss as a sole or predominant symptom, including the 1555A^G  
mutation3 , the 7445A ^G  mutation10 and the 7472insC mutation. 12 PCR amplification from 
lymphocyte DNA followed by digestion with a specific restriction enzyme, was performed in ten 
family members from the maternal line in order to examine the presence or absence o f these three 
point mutations. The 1555A^G  and 7445A ^G  mutations were not present in any o f the patients. 
However, the 7472insC mutation was present in all ten family members. The 208 bp fragment is cut 
into two fragments measuring 168 bp and 40 bp by Xcml in the patients with the mutation (Figure 2).
M 1 2 3 4 5 6 7
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Figure 2:
PCR amplification and Xcml digestion of a mitochondrial DNA fragment (position 7432-7640). In patients II-9, I-1, I-3, II-12 and I-13 with 
the 7472insC mutation (lanes 3 to 7), the 208 bp PCR product is cut into two fragments of 168 bp and 40 bp. The 40 bp fragment is not 
visible on the gel. Due to heteroplasmy, the undigested fragment remains visible. Lanes 1 and 2 show controls in which the 208 bp product 
remains undigested. The left lane (M) contains a 100 bp ladder as size standard.
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In controls, the PCR fragment remains uncut. To prove the presence o f the 7472insC mutation in this 
family by sequence analysis, we PCR amplified and cloned a mtDNA fragment containing the 
7472insC mutation in the tRNASer(UCN) gene from two patients (II-21, I-7). Sequence analysis o f the 
cloned material o f the two patients revealed the insertion of a seventh cytosine into a stretch o f six 
cytosine’s (7467-7472) that is part o f the tRNASer(UCN) gene. Subsequently, all family members o f the 
maternal lineage, including those without hearing loss, were tested by PCR and restriction digest with 
XcmI. They all showed the 7472insC mutation (figure 1). One hundred unrelated normal controls 
were also tested, but we never detected the 7472insC mutation.
In most family members with the 7472insC mutation the normal band remains visible, suggesting 
heteroplasmy for the mutation. Therefore, the percentages o f wild-type and mutant lymphocyte 
mtDNA were analyzed by SPMS. The percentage o f mutant mtDNA observed in each family member 
of the maternal line is shown in Figure 1. Although the heteroplasmy ranges from 12 to 99% mutant 
mtDNA, the majority o f family members showed values between 90 and 99%. In the proband (I-5) the 
heteroplasmy was determined in lymphocytes as well as in muscle. No differences between 
percentages o f mutant lymphocyte and muscle mtDNA were found.
Figure 3.
Hearing threshold (dB HL) plotted against percentage of 
mutant mtDNA in 37 members o f the family. Average 
hearing threshold for the frequencies 0.25, 0.5 and 1 
kHz are indicated by a full circle. Average hearing 
thresholds at frequencies 2, 4 and 8 kHz are indicated 
by an open symbol Patient III-10 (12%, 10 dB low, 10 
dB high) is not included in the figure for clarity.
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Statistical analysis: We statistically tested a possible correlation between the degree o f hearing 
impairment at the low frequencies (0.25, 0.5, 1kHz) and at the high frequencies (2, 4 and 8 ) kHz and 
the percentage o f heteroplasmy. The Spearman’s rank correlation test was not significant (n = 38, r =
0.26 and 0.12) for a correlation between the degree o f hearing impairment and heteroplasmy (Figure 
3). We also failed to find a significant correlation between age and heteroplasmy (data not shown).
Analysis of patients with aminoglycoside ototoxicity: As 3 family members with the 7472insC 
mutation developed hearing loss after the use o f aminoglycosides, we investigated the possibility that 
this mutation causes susceptibility to aminoglycoside ototoxicity. We analyzed the presence o f this 
mutation in 52 patients that suffered from acute hearing loss after the use o f aminoglycosides. 15 
Forty-three o f these patients were unrelated. In seven of them the 1555A^G  mutation was present, 
but the 7472insC mutation was not detected in any of the patients.
DISCUSSION.
We found the previously reported mitochondrial mutation 7472insC in a Dutch family with 
maternally inherited sensorineural, bilateral hearing loss. The fact that the mutation is present in two 
independent families with hearing loss as a predominant symptom12 is strong evidence for the 
pathogenic role o f the 7472insC mutation. Additional support for the disease-causing nature o f this 
mutation includes : i) the segregation pattern o f the hearing loss in the large Dutch family is clearly 
mitochondrial, ii) the mutation was present in all members o f the maternal lineage o f the Dutch and 
the Italian family, iii) the mutation was not present in any o f the 100 Dutch control persons in this 
study, nor in any of the 381 Italian control persons in a previous study12 , iv) the mutation changes the 
conformation of the conserved T ¥C  loop in the secondary structure o f the tRNASer(UCN) gene, v) using 
homoplasmic cybrids it was previously shown that the mutation reduces oxidative phosphorylation 12 
,and vi) the mutation in both families is heteroplasmic , which is considered an indication o f the 
pathogenicity o f the mutation. 16 This mutation was previously reported in a Sicilian family. Of the 
thirteen family members o f the
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Sicilian family with the mutation, four were unaffected, two had only hearing loss, and seven had 
additional neurological symptoms o f which four were severely neurological affected. 12 In the Dutch 
family, 27 o f the 38 family members with the mutation had hearing loss as an isolated symptom. All 
family members above the age o f 30 with the mutation had hearing loss, except for four persons. The 
fact that these four family members have normal hearing might be due to a highly variable age of 
onset or to reduced penetrance o f the hearing impairment. As in the Dutch family only the index 
patient (I-5) had ataxia o f both limbs and dysarthria in addition to hearing loss, the Dutch family has a 
much lower penetrance o f neurological symptoms than the Sicilian family.
We analyzed the percentages o f heteroplasmy in the previously described Sicilian family and the 
Dutch family in relation to the presence or absence o f hearing impairment or neurological impairment 
in patients aged 25 years and over. There was a significant difference in the percentage of  
heteroplasmy between the family members with and without hearing/neurological impairment in the 
Sicilian family (Mann-Whitney test, P < 0.05). In the Sicilian family, a threshold o f approximately 
95% was suggested for the manifestation o f all neurological symptoms in addition to hearing loss . 12 
However, in the Dutch family, 20 family members with 95 % heteroplasmy or more, had no additional 
neurological symptoms. Only the proband, who had the highest percentage o f heteroplasmy (99%), 
had a clear neurological picture. However, it is very well possible that a higher threshold (99%) for 
heteroplasmy is necessary for the manifestation o f the full-blown neurological phenotype in the Dutch 
family. This different threshold must be explained by the influence o f a second factor, environmental 
or genetic. This factor might have a “protective” influence in the Dutch family or alternatively a 
“pathogenic” influence in the Sicilian family. Also for other mitochondrial mutations, additional 
factors are known to be involved, but have remained unidentified. 17,18 Such a factor might be another 
mtDNA variation, as suggested for the 7445A ^G  mutation. However, sequencing o f the complete 
mitochondrial genome would be needed to investigate this possibility in our family.
On the other hand, also nuclear genes may influence the penetrance and expression of mitochondrial 
mutations. The recent finding that mice with a mutation in the myosin VIIA gene are protected from 
aminoglycoside ototoxicity 19 suggests that the myosin VIIA gene may be a nuclear factor influencing 
mitochondrial mutations that predispose to aminoglycoside induced deafness.
71
We investigated possible statistical correlations between hearing impairment and heteroplasmy or 
between age and heteroplasmy. Both were not significant. The absence o f a correlation between 
hearing thresholds and heteroplasmy is remarkable, as the causative role o f the mutation is beyond 
doubt. However, heteroplasmy was determined in blood, and a significant correlation might be found 
in other tissues. Up to now, heteroplasmy levels in muscle have only been determined in a single 
patient o f the Dutch family and in two patients o f the Sicilian family. Although identical values for 
blood and muscle were obtained in these 3 cases, more patients need to be analyzed to perform 
statistics.
It is remarkable that three Dutch family members o f the maternal line reported acute hearing loss after 
the use o f streptomycin. This suggests the involvement o f the 7472insC mutation in susceptibility for 
ototoxic medication. However, the 7472insC mutation was not found in a set o f 45 additional patients 
with aminoglycoside induced hearing loss without the 1555A^G  mutation. This could indicate that 
the presence o f three patients with aminoglycoside induced deafness in the Dutch family is purely 
coincidental. Alternatively, if  the 7472insC mutation does influence the sensibility to 
aminoglycosides, it is probably a rare cause o f aminoglycoside induced hearing loss.
In this study we report a family in which the 7472insC mutation causes non-syndromic hearing loss in 
most patients, and syndromic hearing loss in a single patient. It is therefore obvious that, in addition to 
the 1555A^G  and the 7445A ^G  mutations, the 7472insC mutation is an important mutation to be 
analyzed in families with maternally inherited non-syndromic hearing loss.
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ABSTRACT.
Sensorineural hearing loss affects approximately 1 in 2 persons at about 80 years o f age and 1 in 750 
in childhood. The best known forms of hearing loss with an autosomal dominant pattern of 
inheritance are the syndromic-mediated ones.
At present, the non-syndromic autosomal dominant inherited forms can only be distinguished by the 
shape o f the tone-audiogram. Based on gene linkage studies twelve different genotypes for autosomal 
dominant hereditary non-syndromic forms o f sensorineural hearing loss have been recognized in a 
period of almost two years.*
In view o f the great diversity o f types that have been recognized in such a short period, it can be 
expected that over the next ten years, several dozen genetically-mediated forms of autosomal 
dominant inherited sensorineural hearing loss will be detected.
Similar developments are taking place in the non-syndromic autosomal recessive hereditary forms of  
sensorineural hearing loss and deafness. The above indicates clearly that new genetic investigation 
techniques will enable us to distinguish between forms of sensorineural hearing loss that could not be 
distinguished in the past.
* At the time of preparing this thesis the number expanded to over 36 DFNA genotypes.
INTRODUCTION.
Sensorineural hearing loss affects approximately 1 in 2 persons at about 80 years o f age and 1 in 750 
in childhood. Inaccessibility o f the inner ear to discriminant diagnostic procedures and the great 
diversity o f possible causes o f deafness, are reasons why it can be difficult to establish causes in
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individual cases.
The best known forms of hearing loss with an autosomal dominant pattern of inheritance are the 
syndromic-mediated ones, such as osteogenesis imperfecta type 1 and otosclerosis. At present, the 
non-syndromic autosomal dominant inherited forms can only be distinguished by the shape o f the tone 
audiogram. 1 Progressive sensorineural hearing loss is divided into low frequency, mid-frequency or 
high frequency hearing loss depending on whether the hearing loss is most pronounced in the low 
tone, middle tone or high tone range. Apparently, the possibility that flat progressive perceptive 
hearing loss can also have an autosomal dominant pattern o f inheritance, has been overlooked. 
Depending on the age at onset, various separate types can be distinguished within this classification. 
Table 1 lists the various forms of sensorineural hearing loss that can be distinguished on clinical 
grounds. 1
Table 1
Autosomal dominant inherited types o f hearing impairment that can be distinguished on clinical grounds.
1. Congenital severe sensorineural hearing loss
2. Congenital low-frequency sensorineural hearing loss
3. Progressive low-frequency sensorineural hearing loss with childhood onset
4. Mid-frequency sensorineural hearing loss
5. Progressive high-frequency sensorineural hearing loss
6. Progressive mixed hearing loss
7. Unilateral sensorineural hearing loss
8. Progressive vestibulo-cochlear dysfunction and sensorineural hearing loss
X DOMINANT INHERITED HEARING LOSS.
When speaking in terms of dominant hereditary syndromes, it is necessary to realise that an X- 
dominant pattern o f inheritance is also possible. 2 A well-known example o f the latter is Alport's 
syndrome, characterised by progressive perceptive hearing loss, haematuria, eye
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abnormalities and progressive deterioration of renal function, which until a few decennia ago, was 
considered to have an autosomal dominant pattern o f inheritance. Occasionally, an autosomal 
recessive form of this syndrome is encountered. It is unclear whether there might also be an autosomal 
dominant inherited form. Besides the specific pattern of inheritance, the fact that men are more 
severely affected than women should have drawn attention to the possibility o f an X-dominant mode 
of inheritance at a much earlier date.
NON- MENDELIAN MITOCHONDRIAL INHERITED DEAFNESS.
Mitochondria are small organelles that are responsible for the cell's energy production. They have 
their own circular DNA that codes for the polypeptides necessary for oxidative phosphorylation. 
Mitochondria are passed on to the offspring exclusively by the mother via the cytoplasm in the ovum. 
Every cell contains hundreds o f mitochondria and every mitochondrion contains various copies of 
mitochondrial DNA (MtDNA). Mitochondrial DNA is more sensitive to mutations than nuclear DNA. 
Therefore, some Mt-DNA diseases can arise as a result o f spontaneous mutation, in addition to the 
maternally transmitted MtDNA diseases. Hearing impairment often forms an additional problem, but 
deafness can also be the only expression o f a syndrome.3,4 Table 2A/B gives an overview of the 
currently known Mt-DNA mediated forms o f hearing loss.
Table 2a
Mt-DNA mutations associated with hearing impairment as main/only presenting symptom.
Author Clinical symptoms Hearing impairment Mt-DNA mutation
Hu 7 
Prezant 8
High susceptibility to antibiotic 
ototoxicity aminoglycoside 
(streptomycine) related deafness
Bilateral profound deafness 12SrRNA: A1555G
Jaber 9 
Prezant8
Progressive hearing loss starting in 
childhood
Profound bilateral hearing 
loss without any additional 
symptoms
12SrRNA: A1555G
Vernham 10 
Reid ;Vernham 11 
Fischel-Ghodsian12
Progressive hearing loss Variable hearing loss, 
Predominantly high
frequencies
Onset between 3-18 years
tRNA-ser (UCN): T7445C
Tiranti 13 Bilateral hearing loss, ataxia and 
myoclonus
Moderate to severe hearing 
loss
tRNA-ser(UCN): 7472insC
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Table 2b
Mt-DNA mutation in which hearing impairment is additional symptom.
Author Clinical symptoms Hearing impairment Mt-DNA mutation
Pavlakis 14 Mitochondrial encephalopathy 
episodic nausea and vomiting, 
migraine-like headaches, 
Stroke-like episodes, seizures, 
gray matter spongiosis(MELAS)
Hearing loss in about 30% 
of the cases
Heteroplasmic point mutation in 
t-RNA gene; 3243
Goto15 Mitochondrial encephalopathy, 
lactic acidosis, stroke-like episodes, 
diabetes and deafness
Hearing loss Heteroplasmic point mutation in 
t-RNA gene; 3271
Shoffner16 
Berkovic17-18 
Hammans19 
Silvestri 20 
Zeviani 21
Myoclonic epilepsy and red ragged 
fibres, ataxia, dementia and optic 
atrophy (MERFF)
Hearing loss Heteroplasmic point mutation in 
t-RNA genes; 8344,8356
Zeviani 22
Poulton23
Kearns Sayre syndrome, PEO and 
Pearson syndrome,
Ptosis, retinopathy, heart block, 
Cerebellar syndrome, endocrino- 
pathies, elevated CSF protein,white 
matter spongiosis
Hearing loss Large heteroplasmic duplications 
and deletions in mt-DNA
GENE LINKAGE FOR NON-SYNDROMIC AUTOSOMAL DOMINANT INHERITED 
HEARING LOSS.
In a family with ten to twenty persons affected by an autosomal dominant hereditary anomaly, gene- 
linkage studies can be performed to determine which part o f a chromosome is responsible for the 
genetically-mediated anomaly. The position on the chromosome can be isolated with increasing 
accuracy, because an increasing number of markers are becoming available for which the localisation 
on the chromosome is known. Moreover, it is possible to perform gene-linkage studies on multiple 
families.5 On the basis o f these investigation techniques, twelve different genotypes for autosomal 
dominant hereditary non-syndromic forms o f sensorineural hearing loss have been recognised in a 
period of almost two years. In view of the great diversity o f types that have been recognised in such a 
short period, it can be expected that over the next ten years, several dozen genetically 
mediated forms o f autosomal dominant sensorineural hearing loss will be detected. Owing to the fact 
that large families with autosomal dominant forms of hearing loss are relatively common in Western 
industrialized society, there should be very few obstacles in these developments. Table 3 listst the 
latest developments.
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Table 3
Non-syndromic autosomal dominant inherited types o f sensorineural hearing impairment and their gene linkage.
Linkage McKusick
catalogs
Gene Year Author
DFN A1 5q31 124900 1992 Leon24
A2 IP32 124800 - 1994 Coucke 25
A3 13q12 124800 - 1994 Chaib 26
A4 19p13 124800 - 1995 Chen27
A5 7p15 124800 - 1995 Van Camp 28
A6 4p163 124800 - 1995 Lesperance 29
A7 1q21-23 124800 - 1995 Tranebjaerg30
A8 15q15-21 124800 - 1995 Kirschhofer 31
A9 14q12-13 124800 - 1996 Manolis 32
A10 6q22-23 124800 - 1996 O'Neill 33
A11 11q135 124800 - 1996 Tamagawa 43
A12 - - - - Reserved
* At present 36 autosomal dominant loci have been identified, and several genes have been cloned in DFNA
It can be expected along similar lines that it will even become possible to recognise genetically- 
mediated anomalies on a gene level.5’6 It will then become apparent which substances play a role in 
the physiology and pathophysiology o f the mechanism o f hearing. It was recently discovered, for 
example that myosin VIIA plays a role in the Usher syndrome type 1B. In addition, the clinical 
syndrome, i.e. the variation in severity and progression o f hearing loss, can be accurately documented 
in families in whom earlier successful gene-linkage studies had been completed. Before long, it can be 
expected that textbooks about hereditary non-syndromic forms of sensorineural hearing loss will have 
to be rewritten. It is therefore necessary to document the level o f hearing loss in relation to age and 
the variation in severity o f the hearing loss within each family, so that we can recognise the specific 
clinical symptoms that represent each separate genetic type. In the wake of this, our knowledge about 
the working mechanism of the inner ear will make great leaps forward. Similar developments are 
taking place in the non-syndromic autosomal recessive hereditary forms of sensorineural hearing loss 
and deafness. New techniques will soon make it possible to establish the cause o f deafness in young 
children and the tests can also be used in the form of early diagnostics to make causative genetic 
diagnosis.
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Owing to the fact that large isolates with hereditary autosomal recessive hearing loss are fairly scarce 
in Western industrialised society compared to other parts o f the world , the detection o f these gene 
links and the identification of the genes involved, will be more difficult and time-consuming in 
Western industrialised society. The above indicates clearly that before too long new genetic 
investigation techniques will enable us to distinguish between forms o f sensorineural hearing loss that 
could not be distinguished in the past.
Table 4
Non-syndromic autosomal recessieve inherited types o f sensorineural hearing impairment and their gene linkage.
Linkage McKusick
catalogs
Gene cloned Year Author
DFN B1 13q12 220700 
and 220800
- 1994 Guilford 34
B2 11q135 220700 
and 220800
- 1994 Guilford 35
B3 17p112-q12 220700 
and 220800
- 1995 Friedman et al. 199536
B4 7q31 220700 
and 220800
- 1995 Baldwin 37
B5 14q12 220700 
and 220800
- 1995 Fukushima 38
B6 3p21-14 220700 
and 220800
- 1995 Fukushima 39
B7 9q13-21 220700 
and 220800
- 1995 Jain199540
B8 21 220700 
and 220800
- 1996 Veske41
B9 2p22-23 220700 
and 220800
- 1995 Chaib42
B10 21q223 220700 
and 220800
- 1996 BonnJ-Tamir 44
B11 9q13-21 - - - Scott 45
B12 10q21-22 220700 
and 220800
- 1996 Chaib 46
B13 - - - - Reserved
B14 - - - - Reserved
B15 - - - - Reserved
* At present 29 autosomal recessive loci have been reported and several genes have been cloned in DFNB 
loci.
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ABSTRACT.
We studied a Dutch family with DFNA2 linked progressive sensorineural hearing impairment (SNHI). 
From 18 of the affected persons (aged 7-81 years) the most recent audiogram was obtained and they 
were included in a gene-linkage analysis. Linear regression analysis o f the most recent audiograms, 
using the binaural mean threshold, disclosed a descending slope o f on average about 10 dB/octave; at 
any age, and an annual threshold increase at any frequency of about 0.7 dB/year. There may have 
been substantial (i.e. significantly non-zero) congenital impairment at the higher frequencies, but 
longitudinal analysis o f hearing impairment in the youngest case, who was followed from age 5 years, 
suggested that excessive progression may have occurred in the first two decades o f life.
Linkage analysis was carried out with special attention to the DFNA2 region because hearing trends 
were very similar to families previously linked to DFNA2. Linkage to DFNA2 was established with 
maximum lod scores o f 4.7 and 3.2 for the flanking markers o f the DFNA2 region. No further 
refinement o f the genetic region was possible in this family.
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INTRODUCTION.
Hereditary hearing loss consists o f a heterogeneous group of disorders and is in most forms 
sensorineural rather than conductive in nature. Non-syndromic deafness approximately accounts for 
70% of reported inherited hearing impairment. 1 Of the causes o f prelingual childhood deafness in the 
community at least 50% is attributed to a genetic cause.2 Most inherited forms of childhood hearing 
impairment are attributed to autosomal recessive genes. Autosomal recessive inheritance accounts for 
60-70 % of prelingual hereditary hearing loss. The percentage o f autosomal dominant traits in genetic 
childhood hearing impairment is 20-30 and in most cases postlingual. X-linked and mitochondrial 
forms are rare and together account for 2-3 % o f hereditary hearing impairments.3 Identification of 
non-Mendelian inheritance in man took place only recent. An increasing number o f mutations in the 
mitochondrial genome have been discovered ranging from large scale mutations to specific point 
mutations.4 In the last two decades, a number of syndromic forms of deafness has been identified by 
genetic linkage analysis.5
Less is known of the non-syndromic forms of sensorineural hearing impairment (SNHI), because 
genetic linkage analysis is impaired by genetic heterogeneity. A rapid development in gene mapping 
of non-syndromal autosomal dominant conditions has occurred over the last 5 years.6 Today 36 
autosomal dominant SNHI loci (DFNA 1-36) and 29 autosomal recessive loci (DFNB 1-29) have been 
identified.6
The genes classified as DFNA are characterized by autosomal dominant non-syndromal hearing loss. 
Some show a midfrequency or low-frequency hearing impairment. Mostly the hearing impairment is 
progressive in nature. A precise description o f most phenotypes is still lacking. The DFNA3, DFNA8  
and DFNA12 regions are considered to have stable non-progressive hearing loss. The DFNB genes 
are found in autosomal recessive syndromes and hearing impairment is usually congenital and 
stationary.
In 1994 Coucke et al. linked two unrelated families with different audiological phenotypes to the short 
arm of chromosome 1.7 The locus was named DFNA2. Two additional Dutch and one Belgian family 
with bilateral sensorineural hearing loss starting in the high frequencies were linked to the same 
region.8-10 Subtle differences were found in the audiological characteristics o f these families that 
localize to the DFNA2 region.8,9 Two genes responsible for autosomal dominant reside in the DFNA2 
region. The first gene was
Chapter 3
identified as connexin. (GJB) The second is a voltage gated potassium channel and was identified by 
Kubisch. We report on a additional four-generation family with linkage to the same region. Genetic 
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results will be described elswhere in detail.
Delineation o f the clinical audiological phenotype and a comparison with additional Dutch families 
with hearing loss linked to DFNA2 is given.
METHODS.
Audiometrical examination: In all family members a medical history and general 
otorhinolaryngological examination with otoscopy was performed. Previous audiograms were 
requested for most family members. In most family members pure-tone audiograms were obtained in a 
sound treated room with an Interacoustics AC5 audiometer calibrated according to ISO 389 and ISO 
8253-1 standard. 11 (International Organization for Standardization 1985, 1989) Air conduction 
thresholds were measured in dB hearing level (HL). Bone conduction thresholds were also measured 
to exclude conductive or mixed hearing loss. In all family members the method of ISO 7029 was 
followed to calculate 95th percentile (P95) threshold values for presbyacusis for each patient 
individually at each frequency in relation to the patient's age and sex . 11 Only when a hearing treshold 
greater than the P95, in relation to presbyacusis, was found, the individual was considered to be 
affected.
Owing to the distance and dispersion of many family members throughout the Netherlands, a few 
family-members o f one branch were audiometrically examined by a Madsen AC 40 portable 
audiometer at their houses (branch A). Individuals with other probable causes o f hearing impairment, 
such as noise trauma, frequent otitis media or treatment with ototoxic medication were excluded from 
genetic and audiological analysis.
Statistical methods: Statistical methods comprised linear regression analysis o f the most recent 
audiogram (thresholds on frequency) and of the resulting parameters such as audiogram slope and 
intercept-on the patient's age. Regression analysis o f the mean threshold at 0.25, 0.5, 1, 2 and 4 kHz ( 8  
kHz was not measured in all cases) on age was included. Linear regression analysis o f longitudinal 
threshold measurements for each frequency was applied in 1 case. Confidence intervals for the 
estimated parameters ( slope and intercept) were used to see whether these included zero.
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Genetic analysis: Genomic DNA was isolated from peripheral blood samples. Genetic analysis was 
performed with the microsatellite markers D1S432 and MYCL1, which flank the DFNA2 locus. 10 
Two-point linkage analysis was performed using the MLINK program of the Linkage 5.1 package 
(Lathrop and Laouel, 1984). Penetrance was set at 100%. Recombination frequencies were assumed 
to be equal for men and women. For each marker, the number of alleles in the lod score calculations 
was set at the observed number o f alleles in the pedigree (N), and the allele frequencies were all set at 
1 /N.
FIGURE 1a.
Family picture from 1929 showing the maternal grandmother and her seven children. The family travelled in those days 
through the Netherlands as merchandisers. The oldest children, two daughters and part of their descendants are depicted in 
branch A and branch B of the pedigree.
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RESULTS.
Family: Our study population comprised 19 subjects with probably inherited SNHI from 2 different 
sibships covering 4 generations in one pedigree. The great-grandmother (I1) gave birth to seven 
children (Figure 1A); six were female; one died at an early age.
A total o f 25 individuals were examined. The pedigree o f the family is presented in figure 1B. Except 
for one daughter (II4), all reported to suffer from early-onset hearing impairment. Most children and 
grand-children attended a school for the hearing impaired prior to attending an elementary school 
from the age o f 6 .
FIGURE 1b.
Part of the pedigree of the family investigated. Family members in branch A and B were examined.
Cross-sectional analysis ofaudiograms:
All individual regression thresholds on frequency lines are combined in panel A of figure 2 to show 
that the slopes o f all audiograms were fairly similar, but their intercepts differed. Panels B and C of 
Fig. 2 show the plots o f audiogram slope and intercept (i.e. defined in Figure 2a) against age. It is 
clear that slope did not depend on age. ( Figure 2B)
The mean slope was 10.5 dB/octave (SD 2.4). Both the audiogram intercept (Fig. 2C) and the mean 
threshold at 0.25-4 kHz (Fig. 2D) showed a significantly non-zero slope o f about 0.7 dB/year (residual 
SD-deviations about 11 dB).
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A non-zero slope in Figs 2C,D implies significant progression in hearing impairment with increasing 
age. The mean threshold at 0.25-4 kHz is included here as an additional parameter, because the 
intercept represents an estimated threshold at (only) 0.25 kHz. The intercept in Fig. 2C, i.e. the 
threshold at 0.25 kHz, does not differ significantly from zero, but the intercept in Fig. 2D, i.e. the 
mean threshold at 0.25-4 kHz, does. This suggests the presence o f substantial congenital impairment 
only at the higher frequencies.
Serial audiograms: Sufficient longitudinal data for regression analysis were in 2 cases (III14, IV14) 
available. In the youngest case (IV14) more-than-average progression (25 dB Fletcher index) in SNHI 
is present in the interval o f 7 to 17 years. Perhaps the higher threshold values at age < 7 years can be 
explained by the fact that audiometry in young children can be very problematic and may be biased 
towards higher values. Otitis media could be a different explanation but this was not mentioned in all 
patients record.
Genetic analysis: Up to now five families have been linked with to the DFNA 2 locus on 
chromosome 1p34. In this study we provide evidence o f a sixth linked family to this deafness locus. 
We analyzed this family with two polymorph genetic markers flanking the DFNA2 candidate region. 
The maximum lod scores o f 4.7 and 3.2 for markers D1S432 and MYCL1 respectively clearly proved 
linkage o f this family to the DFNA2 locus. It was already clear that not a single mutation could be 
responsible for the hearing loss in the DFNA2 region. In Figure 4, a schematic presentation o f the 
family haplotype is given. As all affected family members share the same haplotype, no recombinants 
between the analyzed markers and the DFNA2 locus or phenocopies are present in this family.
Figure 2. (top)^
(A) Plot of all individual audiogram regression lines in audiogram layout. (B) Plot o f individual audiogram slope vs patient age. (C) Plot of 
individual audiogram intercept (obtained from A) vs age. (D) Plot of mean individual threshold at 0.25, 0.5, 1, 2 and 4 kHz (8 kHz was not 
available in some cases) vs age. The regression equations (parameter values: mean "SD) in C and D are y = (0.66"0.18)x + (3.78"8.47) and y 
=(0.67"0.14)x + (24.5"6.48), from which it appears that the intercept of the regression line in panel C does not differ significantly from zero, 
but that in panel D does.
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Figure 3.( bottom)
Serial audiograms in 2 individual cases. (III14 and IV14). Lines shown in panel A are connecting lines, those in panel B are regression lines.
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Figure 4.
Pedigree of the family members used in the genetic study. Black symbols represent affected members. Squares are used for males, circles for 
females. Below the symbol, the chromosome 1 haplotype is given. The haplotype linked to DFNA2 is flanked by a solid bar, other 
haplotypes are flanked by open bars.
DISCUSSION.
This is the sixth reported family that discloses positive linkage to the DFNA2 region on 1p34. Half o f  
the families are Dutch; the others are from Belgium, the USA and Indonesia. Of so far all published 
Dutch families with autosomal dominant hearing impairment, all but one 12 are linked to chromosome 
1; the DFNA2 region might be relatively frequent in inherited progressive high-frequency hearing 
impairment.
All DFNA2 families demonstrated pronounced high-frequency impairment. In most affected family 
members, although onset-age varied considerably, hearing impairment became apparant before the 
third decade o f life. Although no vestibular testing was performed in this family, individuals that 
carry the DFNA2 mutation generally have intact vestibular function.8,13 This family's trait displays the 
pattern of autosomal dominant inheritance. All affected family members have an affected and 
unaffected parent and two male-to-male transmissions were noted, any concomitant causes for 
hearing impairment 
were absent.
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Cross-sectional analysis in this family disclosed age-dependent progression o f SNHI at a rate o f about 
0.7 dB/y, at all frequencies. Although there was a suggestion that significant high-frequency SNHI 
already occurred prelingually, longitudinal analysis o f our youngest case showed that more-than- 
average progression in SNHI may have occurred between the ages o f 7 and 17 years. However, the 
longitudinal analysis in these individuals may have been biased as follow-up of hearing impairment 
tends to be only performed in individuals with problematic progression. In this case, serial audiometry 
at a younger age had produced higher threshold values than at the age o f 7-10 years, but this may have 
been due to problematic measurement at a young age. Anyway, the single longitudinal observation 
suggests the existence o f some degree o f prelingual impairment in this trait, as was already considered 
in the other two Dutch families with the DFNA2 trait. The substantiality o f a prelingual onset of 
hearing impairment can only be fully appreciated when more longitudinal data on young family 
members with the DFNA2 trait will be available. In this context it is remarkable that the majority of 
the affected youngest generation o f this family attend a school for the hearing impaired.
It may seem fortunate that hearing impairment at age < 10 y and frequency < 4 kHz (on average < 40 
dB) is fairly limited but, given the inherent variability in thresholds, this does not exclude the 
possibility that hearing impairment in some individuals may be to such an extent that it might be 
characterized as marginally prelingual.
A similar trend was detected in two previously reported Dutch families.8,9 Systematic comparison of  
the findings in the present DFNA2 family yields higher annual threshold increases (1 dB/yr) and 
lower mean offset thresholds values (13-15 dB; 0.25 kHz-2 kHz) in 2 closely similar families.8,9 
This family shows a higher offset but slightly less rapid progression. As a result, estimating from 
regression lines at age 43 years, i.e. average age in the present family, the average threshold at each 
frequency was almost similar within 3 dB, while in the other Dutch family it was on average only 
some 4 dB higher. The previously reported Indonesian family showed a predominance o f higher 
thresholds by middle age, whereas additional data indicated post-lingual onset and excessive 
progression in the first two decades o f life. Today this Indonesian family remains the only family with 
linkage to DFNA2 without a detected mutation in the GJB3 gene or KCNQ4.
In the non-syndromal forms of sensorineural hearing impairment DFNA11 and DFNB2, it is found 
that the myosin VIIA gene is altered. Recently a defect in connexin 26 (Cx26) was detected for 
DFNB1 and DFNA3 . 15-16 Mutations in TECTA, present in DFNA8  and DFNA12 families is thought 
to be a candidate gene in these families. 17 In DFNA15 the human homologue o f mouse POU4F3 was 
mapped in an Israeli jewish family. 18
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Recently two deafness genes have been identified that reside on chromosome 1p34. The first gene 
belongs to the connexin family. Connexins are structural molecules for gap junctions, which allow 
passing o f small molecules between neighbouring cells. A novel member o f the connexin family, 
connexin 31 (GJB3) was found to be responsible for the hearing loss in two small Chinese families. 
Patients in these families suffered from bilateral high frequency impairment. Remarkedly they found 
these mutations in female carries with no apparant hearing problem and suggested that a genetic factor 
may compensate for the effect o f the mutation. The second DFNA2 gene is a voltage K+ channel , 
named KCNQ4. Mutations in this channel were first found in a small French family with autosomal 
dominant hearing loss, and later in 4 large linked families. Expression studies indicated that KCNQ4 
is expressed on the basolateral side o f outer hair cells. It is believed that KCNQ4 is responsible for the 
removal o f excessive K+ after stimulation of the outer hair cells. Dysfunctional outer hair cells would 
give a hearing loss that does not exceed 60 dB. However hearing loss over 60 dB has been 
demonstrated in DFNA2 families. Oto-acoustic emissions, although not performed in our families, 
could help unravel this mechanism especialy when performed in the young. Mutation analysis in 
patients o f this DFNA2 family will reveal whether one o f the two DFNA2 genes (GJB3 or KCNQ4) is 
responsible for the hearing loss.
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The genetic results and mutation analysis of the Dutch III family will be published soon.
Mutations in the KCNQ4 K+ channel gene responsible for autosomal dominant hearing loss 
cluster in the channel pore region.
Van Hauwe P, Coucke P , Ensink R, Huygen PLM, Cremers CWRJ, Van Camp G.
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ABSTRACT.
Objective: To establish a genotype-phenotype correlation in 6  DFNA2 families.
Design: Survey.
Setting: University Hospital Departments Antwerp, Nijmegen, Omaha.
Patients: Affected members o f 6  unrelated families with mutations in KCNQ4 gene.
Main Outcome Measures: Phenotype description based on cross-sectional linear regression of hearing 
threshold on age at each audiogram frequency. Statistical and visual comparisons o f regression lines 
between families. Correlation o f findings with genotype data.
Results: The Indonesian family, whose phenotype differed considerably from those o f the others, had 
no KCNQ4 mutation, while the other families all had different mutations in this gene. The Belgian 
family, who had a frameshift mutation causing truncation of the protein before the first 
transmembrane domain, showed only progression (by about 1.25 dB/year) at the high frequencies, 
whereas all 4 remaining families showed almost equal progression (by about 0.7-1 dB/year) at all 
frequencies. The Dutch families I, II and III and the American family all had missense mutations 
likely to affect the integrity o f the K+-selective channel (pore region) that forms part o f the expressed 
voltage-gated K+ channel protein. Pairwise interfamilial comparisons disclosed a considerable 
similarity in phenotype between these 4 families, whereas their phenotypes were clearly different 
from those in the Belgian or Indonesian family.
Conclusion: All missense mutations affecting the pore region of the expressed KCNQ4 protein seem 
to relate to a well-defined set o f fairly or partially similar phenotypes.
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INTRODUCTION.
Up to about 10 years ago the diagnosis and classification o f hearing impairment was based on about 5 
clinical characteristics.1 One of these is the age o f onset, which can be roughly distinguished into 
prelingual and postlingual onset; this appeared to be very useful in the study of young affected 
children, on whom many data were available. The prevalence o f prelingual sensorineural hearing 
impairment (SNHI) is about 1/1000 (both ears 80dB) and a genetic cause is probable in about 60%.2,3 
The mode of inheritance is autosomal recessive in 70%-80% of the cases, autosomal dominant in 
20%-30% and X-linked in 1%-2% . 2-4 In about 75% of the hereditary cases o f prelingual sensorineural 
deafness, a non-syndromic phenotype is found. 1,3 Much less is known about postlingual hearing 
impairment. In young adults in the western world the prevalence o f postlingual hearing impairment is 
about 1% and it is estimated that this increases to 10% and 50% at the ages o f 60 and 80 years, 
respectively.2 The proportion of hereditary causes amongst these cases is unknown. Most o f these 
cases represent autosomal dominant disorders.
The classification of inherited non-syndromic sensorineural hearing impairment is increasingly being 
based on molecular-genetic diagnosis.5 The different loci on the genome are indicated by DFNA for 
autosomal dominant, DFNB for autosomal recessive and DFN for X-linked inherited sensorineural 
hearing impairment. At the moment o f writing, there are 36, 29 and 8  different loci for DFNA, DFNB 
and DFN, respectively. The number o f loci is still increasing and it is obvious that non-syndromic 
hearing impairment comprises a wide variety o f genotypes. In a growing number of cases the disease- 
causing mutation has been found. Quite remarkably, in most o f these genotypes relatively little has 
been reported about the corresponding phenotypes. Most DFNA loci relate to only one documented 
family each. DFNA2 (chromosome 1p34) is an exception because at least 8  documented families have 
now been linked to this locus. Phenotypes have been briefly outlined in a previous report.6 More 
detailed phenotype descriptions o f 3 o f the DFNA2 families have also been published.7-9 All 3 
families (2 Dutch, 1 Indonesian) showed symmetrical high-frequency postlingual hearing impairment, 
progressive for all frequencies. Analysed in parallel, the phenotypes o f the 2 Dutch families appeared 
to be fairly similar a similar, with a possibly, congenital, onset and an average progression at all 
frequencies o f about 1dB/year.5 The Indonesian family showed onset in between 11-38 years and 
hearing impairment was generally more severe than in any of the other families.
104
Autosomal dominant hearing loss
Progression was on average 0.8-1 dB/year at most frequencies. To properly assess wether or not there 
was heterogeneity in phenotype, we analysed the 3 above-mentioned families using the same methods 
and included in our analysis the unpublished phenotype data o f 2 additional families (1 Belgian, 1 
American) previously linked to DFNA2, 6,10 as well as a third Dutch family newly linked to this 
locus. 11 The present phenotype analysis was completed before we knew about the recent identification 
of the KCNQ4 gene that is involved. 1213 For the sake o f objectivity, we made no essential changes to 
the phenotype analysis, afterwards.
MATERIALS AND METHODS.
We studied pure-tone hearing (air conduction) thresholds previously obtained in the usual way with 
common clinical equipment in persons affected with DFNA2-linked sensorineural hearing 
impairment, who had a mutation analysis o f the KCNQ4 gene, in relation to their age. Statistical 
methods comprised linear regression analysis of the binaural mean hearing threshold (in each subject 
at each frequency) on age to see whether the regression coefficient - here called ‘annual threshold 
increase’ (ATI) and expressed in dB/y - and offset - which might represent a congenital component of 
sensorineural hearing impairment - differed significantly (P < 0.05) from zero. Interfrequency 
comparisons were made within each family and interfamily comparisons at each frequency to test for 
differences between regression lines. These comparisons were performed using a linear regression 
analysis program (with F test options, Prism program version 2.0, GraphPad, San Diego, USA) that 
first tested on slopes and then only on intercepts if the slopes were not significantly different. Pooled 
estimates were made if possible. To test for differences in ATI or offset at a given frequency between 
the families, we performed one-way analysis of variance (ANOVA, using number, mean and SD 
entries). In addition, we performed multiple family comparisons where relevant. For the given k 
multiple pairwise family comparisons per frequency (k = 15 for 0.25-2 kHz, 10 for 4 kHz and 6  for 8  
kHz, after exclusion of possibly biased estimates), we used the Welch-corrected t test, with the level 
of significance adjusted according to Bonferroni (P = 0.05/k to correct for the otherwise k-fold 
increased tail probability). As a final check on the (dis)similarity between a given pair of families, 
which had been detected in the separate comparison tests, we performed visual
judgement of plots that for each relevant frequency combined the threshold-on-age scatter plots and 
regression lines for the two families in different colours.
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RESULTS.
The threshold data for all families and frequencies and the corresponding regression lines are shown 
in Figure 1. Progression (i.e. slope, or ATI significantly higher than zero) was significant at almost all 
frequencies. Offset values generally differed significantly from zero at the 3 highest frequencies in all 
families and, in addition, at the 2 or 3 lowest frequencies in the American, Belgian and Indonesian 
families.
Testing on ATI (slopes) between the frequencies within each family revealed that ATIs were not 
significantly different and could be pooled (range 0.7-1.0 dB/y), except in the American and Belgian 
families. In the latter two families, there was no test performed on offsets across all frequencies, but 
these were found to be significantly different in all the other families. In the American family, the 
frequencies 0.25-1 kHz could be pooled for ATI (~ 0.4 dB/y), but not for offset sensorineural hearing 
impairment. This also applied to the frequencies 2-8 kHz, where the ATI was about 0.8 dB/y.
In the Belgian family, the low frequencies (0.25-1 kHz) could be pooled and this produced values of 
about 0.25 dB/y for the ATI and about 10 dB for the offset. The higher frequencies (2-4 kHz, note that 
8  kHz was possibly biased) had a pooled ATI of 1.25 dB/y, but offsets were significantly different. In 
the American and Belgian families, significant differences in offset across all frequencies are 
indicated by the finding of significant differences in offset between the above-mentioned subgroups of 
frequencies.
Testing between the families at given frequencies showed that only the Dutch families I and II were 
fairly similar in almost every respect, i.e. both in ATI and offset values, at all frequencies (Figure 2). 
The Dutch family III and the American family showed fairly similar features at 2-8 kHz, but at 0.25-1 
kHz the American family showed (significantly) lower ATIs and higher offsets (Figure 2). The 
American and Indonesian families had fairly similar offsets (at 0.25-2 kHz), but the American family 
showed (significantly) lower ATIs at the lower frequencies (Figure 2). The frequencies 4-8 kHz were 
excluded from the latter comparison, because the threshold data were biased by saturation in the 
Indonesian family.
FIGURE 1. (opposite)
Composite plot of binaural mean hearing threshold (dB HL) against age (year) with the regression lines at the frequencies
0.25-8 kHz for the separate families (panels).
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FIGURE 2.
Superposition of regression lines for the Dutch families I and II (dashed lines ), the Dutch family III , the American family 
(dashed lines ) and the Indonesian families at the frequencies specified for the continuous lines.
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A qualitative description of the distinguished phenotypes is given below with the KCNQ4 mutations 
and the predicted protein. 13 ( Table 1)
Family Progression Offset KCNQ4
Defect
Protein
domain
Significant Equal at Significant Increases with 
frequency at
Dutch I All freqs All freqs High freqs All freqs 
(mildly)
W276S Pore region
Dutch II All freqs All freqs High freqs All freqs 
(mildly)
G321S S6*
Dutch III All freqs All freqs High freqs All freqs 
(mildly)
L274W Pore region
American High freqs 
More than 
Low freqs
High freqs 
separate from 
low freqs
All freqs All freqs 
(mildly)
G285C Pore region
Belgian High freqs High freqs High freqs 
(up to high 
values)
All freqs
High freqs 
(sharply)
FS71 N-terminal
cytoplasmatic
Indonesia All freqs All freqs (up to high 
values)
All freqs 
(mildly)
None
TABLE 1: Description of all families with DFNA2 phenotype and their generic defect.
The Dutch families I and II belonged to the only apparently interfamilial phenotype, for which 
common characteristics are presented here. The above stipulated (dis)similarities between the other 
familial phenotypes can be appreciated from this table and from Figures 1 and 2. Figure 1 can also be 
used to get a general impression of each family’s characteristic age-dependent sensorineural hearing 
impairment features. Allowing for a bias in the regression at the highest frequencies in the groups 
with most severe sensorineural hearing impairment (see above), the following crude typical patterns 
emerged.
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The Dutch families and the Indonesian family showed a fairly similar pattern o f an approximately 
parallel increase in sensorineural hearing impairment with age (i.e. fairly similar ATIs within each 
family) at all frequencies (generally by an ATI of 1 dB/y). In these families, the average distance 
between adjacent frequencies - i.e. the threshold increase per octave, which can be also approximated 
by calculating the difference in mean threshold (pertaining to the mean age within a given family) 
between the corresponding frequencies was in the range o f 5-12 dB/octave at the lower frequencies 
and 10-15 dB/octave at the higher frequencies. Fairly similar values were estimated for the American 
family. In the Belgian family, only little threshold increase between adjacent frequencies from 0.25 to 
1 kHz but at the higher frequencies an estimation was obtained o f as much as 30-35 dB/octave.
A graphical representation of the KCNQ4 voltage gated K+ channel is shown in Figure 3.
FIGURE 3.
Schematic representation of the KCNQ4 channel voltage K+ channel. Transdomaine, S1-S6, as well as the pore region are 
visualized. Four mutations are localized in or near the channel pore. The other in the S1 domain. (Belgian family)
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DISCUSSION.
It was not very surprising that the Indonesian family showed no mutation in the KCNQ4 gene. Not 
only did the DFNA2 candidate region for this family show no overlap with the KCNQ4 region; the 
phenotype was also fairly different from that in the other families. 13
Apart from the Indonesian family, the Belgian family showed striking dissimilarities with each o f the 
other remaining families. As pointed out elsewhere, 13 the 13 bp deletion 211-224 in exon 1 in this 
family causes truncation o f the expressed protein before the first transmembrane region of the 
voltage-gated K+ channel protein, which is therefore nonfunctional. A striking finding in this family 
was that it showed the purest type o f high-frequency hearing deterioration among the present DFNA2 
families, whereas the low frequencies showed only very limited involvement. (Figure 1)
Most o f the remaining families, the American family and the 3 Dutch families, showed at least some 
degree o f mutual similarity in our phenotype analysis, which changed in detail depending on the 
attempted type o f bias correction and should be looked at with considerable reservations as discussed 
above. However, direct visual inspection of the raw data (upper 4 panels in Figure 1) confirms the 
general impression of a considerable degree o f similarity between these 4 families. All o f these 
families have mutations which affect the P-loop domain, or the adjacent S6  domain of the expressed 
KCNQ4 gene product and therefore are likely to cause abnormal K+-selective channel pore function. 
Kubisch et al. 12 reported prominent expression of the KCNQ4 product in the outer hair cells and 
suggested a role in recycling K+ ions.
Comparing the audiometric characteristics o f the Belgian family on the one hand, with those o f the 
Dutch families on the other hand, there is a striking difference. In the Dutch families the slope o f the 
progression of the hearing loss is similar for all frequencies. In the Belgian family the extent and 
progression o f the hearing loss is similar to the Dutch families only for the frequencies above 1500Hz, 
the lower frequencies being involved to a lesser extent. This observation supports a 10 years old 
concept introduced by Pujol o f the "two cochleas" . 14 With this concept he stresses the differences in 
function between the apical and basal parts o f the cochlea. The argumentation was based on 
differences between the apical and basal outer hair cells regarding morphology, bio-electrical 
propertities, afferent and efferent innervation and intracellular physiology. The comment was made 
that apical outer hair cells were behaving rather more like inner hair cells.
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Recently electrical tuning differences between apical and basal outer hair cells could also be 
demonstrated at the molecular biological level in the avian cochlea, based on alternative splicing o f a 
gene responsible for a K+ channel and preferential expression o f the beta unit o f that K+ channel in the 
apical regions. 15
Mutations o f the KCNQ4 gene have been proven to be responsible for the DFNA2 hearing impairment 
of the Dutch and Belgian families. The effects o f the different mutations are substantially different. 13 
The site o f expression of KCNQ4 is in the outer hair cells. 12 The hypothesis was advanced that 
KCNQ4 is important for the basolateral removal o f K+ from hair cells, a chronic overload o f K+ 
leading to slow degeneration o f the cells.
The Belgian family shows an inactivating mutation probably leading to a lower production 
(haploinsufficiency) o f the KCNQ4 subunits and therefore to a reduced capacity o f basolateral efflux 
of K+-ions. In the Dutch families, the mutation resulted in dysfunctional subunits, which are 
incorporated in the heteromeres and may lead to a stronger dominant negative effect than the merely 
decreased formation of heteromeres. The difference in audiometric characteristics between the 
Belgian and Dutch families seems to be related to the capacity and the need for K+ efflux from the 
outer hair cells. Further fundamental research is necessary to determine which mechanism is 
prevailing ; higher K+ influx into the basal outer hair cells due to their pronounced contractily 
properties, or preferential expression of KCNQ4 in the apical outer hair cells. An example o f the first 
hypothesis o f differences in metabolic K+ requirement is demonstrated by the KCNQ1 and KCNE1 
genes, in which the heterozygous mutation leads to merely cardiac manifestations (long QT 
syndrome) and homozygosity to deafness and cardiac symptoms in the Jervell and Lange-Nielsen 
syndrome. 16-18 An example o f the second hypothesis, preferential expression, is mentioned above.15 
It would seem that detailed studies on the correlation between genotype and phenotype in additional 
DFNA2 families, combined with the rapid progression in the study o f the basic molecular-genetic and 
(patho)physiological processes involved, will favour our understanding o f some of the basic 
mechanisms underlying normal and impaired hearing.
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ABSTRACT.
We present a Dutch family with autosomal dominantly inherited mid-frequency and high-frequency 
sensorineural hearing impairment. In this four-generation family compromising 79 individuals alive, 
genetic linkage to DFNA13 was found in 20 persons. Recently, mutations in the COL11A2 gene 
were found in two other families with non-syndromic hearing impairment linked to DFNA13. The 
majority of the affected persons presented with hearing impairment from the age of 30 years onwards, 
although in two affected persons, hearing impairment was noted at about 10 years of age. Three 
individuals represent phenocopies.
After correction for presbyacusis, hearing impairment was most marked at 1-2 kHz and showed an 
annual progression of 0.8 dB per year. By age 60, the configuration of the audiogram was flat, 
reflecting the combined effects of the inherited progressive hearing loss and presbyacusis. Vestibular 
function was intact. We analyzed the COL11A2 gene in this family for mutations using single 
stranded confirmational polymorphism analysis but no mutations were found.
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INTRODUCTION.
Approximately 1 child in 2000 is born with or later develops hearing impairment as a result of an 
inherited genetic defect.2 In recent years, enormous progression has been made in the identification 
of genes responsible for hearing impairment. Classification of types of deafness according to 
genotype has been performed by several working groups on deafness and several websites have been 
established. 3 This classification is now challenging the clinical categorization of deafness subtypes 
based on age-of-onset and audiogram shape.4 Presently, 36 loci for autosomal dominant hearing 
impairment (DFNA - DFN, deafness; A, autosomal dominant) have been identified and 10 of the 
relevant associated genes have been cloned (Table I). 5-14
TABLE 1: Autosomal dominant loci and their cloned genes
Locus Localization Gene
DFNA1 5q31 HDIA15
DFNA2 1p32 GJB3,6 KCNQ47
DFNA3 13q12 GJB2 8; GJB6  9
DFNA4 19q13
DFNA5 7p15 DFNA5 10
DFNA6 4p16.3
DFNA7 1q21-q23
DFNA8 1 1q TECTA11
DFNA9 14q12-q13 COCH 12
DFNA10 6q22-q23
DFNA11 11q12.3-q21 MYO7A 13
DFNA12 11q22-q24 TECTA 11
DFNA13 6p21.3 COL 11A2 1
DFNA14 4p16
DFNA15 5q31 POU4F3 14
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DFNA16 2q24
DFNA17 2 2 q
DFNA18 3q22
DFNA19 10  pericentromeric
DFNA20 17q25
DFNA21-22 reserved
DFNA23 14q
DFNA24 4q
DFNA25 12q21-24
DFNA26 17q25
DFNA27 4q12
DFNA28 8 q2 2
DFNA29 reserved
DFNA30 15q26
DFNA31-36 reserved
Most DFNA loci are associated with hearing impairment that is postlingual in onset, often beginning 
before the age of 20 years, although DFNA4, DFNA9 and DFNA10 are characterized by hearing 
impairment that starts during the 3rd and 4th decades of life.15,16,17 Of the cloned genes that cause 
autosomal dominant hearing impairment, a distinction can be made in genes controlling the function 
of sensory hair cells and nerves (POU4F3, MYO7A, COCH), genes controlling ion endolymph 
homeostasis ( KCNQ4, GJB2, GJB3), and genes essential for tectorial membrane structure (TECTA, 
COL11A2). The function of DFNA5is unknown.
Three loci (DFNA12, DFNA13, DFNA21) are associated with phenotypes characterized by mid­
frequency hearing impairment, and for two of these the genes have been identified. 1,11,18,19,20 
Mutations in TECTA cause hearing impairment at the DFNA12 locus that is prelingual and probably 
congenital in nature.
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Mutations in COL11A2 cause deafness at the DFNA13 locus that is also post-lingual similar although 
by adulthood, the additive effect of presbyacusis produces a flattened audiogram. The gene product of 
TECTA is an essential non-collageneous component of the tectorial membrane. It is known that type 
XI collagen has a function in the maintanance of interfibrillar spacing of type II collagens in cartilage, 
and there is evidence that it fulfills the same function for the type II collagen present in the tectorial 
membrane. It is therefore likely that the hearing loss in these DFNA12 and DFNA13 families is 
pretransductive, and reflects a change in the mechanical properties of the tectorial membrane. In this 
paper, we present a four-generation family linked to DFNA13 with relatively late-onset sensorineural 
hearing impairment. Affected family members develop noticeable hearing impairment in the third 
and fourth decades of life that progressively worsens. Mutation analysis of the COL11A2 gene in 
affected family-members didn't reveal a disease causing mutation.
PATIENTS AND METHODS.
After informed consent was obtained, a pedigree spanning four generations was constructed. A 
general otolaryngological examination was performed on key subjects, paying special attention to 
possible occurrences of acquired hearing impairment. These cases were excluded from the linkage 
analysis. Persons with proven linkage to DFNA13 (n=20) were included in a serial audiological 
analysis. This type of rigid selection is especially relevant because of the relatively late onset at the 
time of the otological and audiological examinations, the youngest individuals in generation IV 
showed only minor hearing impairment at the higher frequencies.
Audiological examination
Pure-tone audiograms were obtained in a sound-treated room according to common clinical standards. 
The ISO norm for presbyacusis 21 was used to identify persons with thresholds above the 95th 
percentile (P95) of presbyacusis, and genetic linkage analysis was performed using these individuals. 
The subsequent analysis of hearing threshold in relation to age are based on data from these persons.
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Threshold-on-age data were analysed by linear regression analysis at separate frequencies, using the 
Prism program (PC version 2.01 GraphPad, San Diego, CA, USA).
Cross-sectional analysis was performed using all suitable last-visit audiograms, and 
longitudinal analysis was performed in those instances in which a sufficient number of serial 
audiograms had been obtained over a sufficient age range.
Binaural mean threshold values were used, after using the Prism program's F-test ANOVA option to 
show that at each frequency, the regression lines for both ears were generally not significantly 
different. We used the students t-test to determine whether the annual threshold increase (ATI) was 
significantly greater than zero. The Prism program was used to obtain an equivalent fit of the line Y= 
slope (X-Xo ), where Xo is age-of-onset, to obtain 95% confidence intervals for age-of-onset. These 
confidence intervals were used to determine whether this age differed significantly from zero.
Vestibulo-ocular examination
Vestibular tests were performed in persons with hearing impairment in the dark with the eyes open. 
Eye movements were recorded by means of direct current (dc) electro-oculography. Gaze positions 
were tested to see if there was any gaze-evoked nystagmus. Saccade metrics, as well as optokinetic 
nystagmus, were evaluated. The vestibulo-ocular-reflex was tested with velocity step tests of 900/s 
using a rotary chair and caloric tests. Results were catagorized as normal, hyporeflexia, hyperreflexia 
or areflexia, and unilateral caloric hyporeflexia ( P< 0.05). Binomial distribution statistics were used 
to test whether the occurrence of certain features, or a combination of features, occurred more often in 
the sample of patients examined then would be expected on the basis of chance alone ( P<0.05).
Genetic analysis
In all individiuals of the family, 20 ml of venous blood was taken. Standard procedures were used to 
extract genomic DNA. We used the linkage computer program to calculate the corresponding LOD 
scores.22 Single strand confirmational analysis of COL11A2 was performed as previously described. 1
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RESULTS.
The pedigree of the family is shown in Figure 1. The family comprises 90 individuals spanning 4 
generations with 7 related family branches. An autosomal dominant pattern of inheritance appeared 
with male-to-male transmissions of hearing impairment over three generations is present. No 
associated syndromal abnormalities were found.
Figure 1.
Pedigree of the family with a autosomal dominantly inherited hearing impairment Black symbols represent individuals with 
hereditary hearing impairment , and open symbols, individuals with normal hearing.
Dots indicate individuals with linkage to DFNA13 without hearing impairment.
On the basis of the audiograms and the absence of any possible other causes of hearing impairment,
12 individuals were, initially, included in the audiological analysis. Following genetic linkage 
analysis, eight additional individuals were included. All of these individuals showed positive linkage 
to DFNA13; six reported a history of tinnitus. A detailed description of the linkage analysis will be 
reported elsewhere.
122
Chapter 3
Audiograms
Figure 2 shows the audiograms obtained from the 20 persons used to establish linkage to the DFNA13 
locus. Case II7 was exceptional for excessive hearing impairment related to noise exposure and 
radiation therapy for a head and neck malignancy. Case III13 also was exceptional as her hearing 
loss was different and she had no ear disease. Although both were carrier, they were excluded from 
the audiological analyses. Non-penetrance was found in 3 persons (III12, III14 and III28).
The shape of the audiogram was flat or gently up-sloping in a few persons but most commonly was 
gently (n=7) or steeply (n=5) down-sloping. The suggestion of a U-shaped audiogram was found 
only in case III27 and perhaps case III17 , however it is clear that after correction for (P50) 
presbyacusis, more U-shaped audiograms appear. The remaining individuals were too young to have 
developed a characteristic type of hearing loss.
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Figure 2.
Audiograms of the 20 cases with linked DFNA13 genotype. The audiograms were obtained at the age (y, in years) indicated 
in keys to the symbols from the right (R) and the left (L) ear (threshold in dB hearing level =HL). Note that the cases are 
presented in order of age at the last-visit audiogram. The cases III 14 , III28 and IV28 , who presented with threshold > P95 
of presbyacusis at only one or no frequency in either ear, presumably represented non-penetrance.
Figure 3 shows the results of the cross-sectional analysis. Progression was significant: the ATI was 
significantly greater than zero at all frequencies. Onset age was significant at 2 and 8 kHz for the 
binaural threshold (at 8 kHz in the right ear ; at 1, 2 and 8 kHz in the left ear ), with values of 10-13 
year. The regression lines could be pooled for 0.25-0.5 kHz and for 2-8 kHz. ATI's were in the range 
of 0.6 dB/y (0.25-0.5 kHz) to 1.1 dB/y (2-8 kHz), whereas onset ages were in the range of 5 y (0.25­
0.5 kHz) to 12 y (2-8 kHz). Informal regression analysis on threshold-on-age data "corrected" for P50 
presbyacusis disclosed that progression was still "significant" at all frequencies after such correction. 
This observation suggests that there was progression of presbyacusis at all frequencies.
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After this correction, the most prominent progression was found at 1-2 kHz ("corrected" ATI about 
0.8 dB/y). A significant "corrected" onset age was only found at 1 kHz for the binaural threshold, 
although at 2 kHz it was close to significant. The disappearance of significant onset age at 8 kHz by 
presbyacusis correction suggests that onset age at this frequency may have been biased towards 
higher values by the effect of presbyacusis.
Figure 3.
Cross-sectional analysis with linear regression of threshold (binaural mean in dB HL) on age (y) for the separate frequencies 
as measured at the patient's last visit. The fat lines show the pooled regression for the frequencies as indicated. The values in 
parentheses are the ATI values (dB/y) and the values shown close to the X intercepts are the extrapolated onset ages (y). All 
20 cases with linkage to DFNA13 were included in this analysis.
LONGITUDINAL ANALYSIS OF HEARING THRESHOLD ON AGE.
Suitable serial audiograms were available only in case III2 (Fig. 4). Progression was significant at all 
frequencies with ATI values of 0.5 to 1.6 dB/ y. The regression lines in this case were compared to 
those obtained in the cross-sectional analysis. ATI's were fairly similar, as were the intercepts at 
0.25-1 kHz at these frequencies. Case III2 showed a significant onset age at the higher frequencies, 
the positive Y intercept (offset level) differed significantly from zero at 8 kHz, suggesting either a 
high congenital offset
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threshold and/or leveling of progression over the age range we studied. Correction for presbyacusis in 
case III2 at 4-8 kHz cancels any DFNA13-associated progression of hearing loss, although at the other 
frequencies, the ATI remained significant at 0.7-1.3 dB/y. The significant onset age at 0.25 kHz to 1 
kHz decreased only slightly by correcting for presbyacusis.
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Figure 4.
Longitudinal analysis of the linear regression of threshold (binaural mean in dB HL) on age (y) in case III2. The Y intercepts 
of the regression lines were clearly different between most of the frequencies, but the slopes could be pooled for the 
frequencies 0.25-4 kHz (pooled estimate ATI = 1.2 dB/y).
VESTIBULO OCULAR EXAMINATION.
Seven persons with hearing loss underwent vestibulo-ocular examination. Person IIIi9 showed 
bilateral caloric weakness and hyporeflexia in the VS test (short time constant in 1 direction, low 
Gesamtamplitude in 2 directions). Persons III6, III7 and IIIi7 showed hyperactive vestibulo-ocular 
reflexes (VOR) with high Gesamtamplitude but normal caloric responses. Only one case, III19 , also 
had bilateral caloric weakness. All four persons reported susceptibility to motion sickness.
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GENETIC ANALYSIS.
Because of the linkage to DFNA13 in this family , and because COL11A2 mutations were found in 
two other families with a similar phenotype, we analysed the COL11A2 gene for mutations in this 
family. Mutation screening of COL11A2 was performed by a single strand confirmational 
polymorphism analysis. Although in several familymembers mutations were found in the exon 5 ; this 
was not be considered as a disease causing mutation.
DISCUSSION.
The European Work Group on Genetics of Hearing Impairment has categorized mid-frequency 
hearing impairment as impairment from 0.5 kHz to , and including 2 kHz with at least a 15 dB 
difference between the poorest threshold in this frequency range and the best threshold in the lower 
and higher frequency ranges. 23 The analysis of this family shows that, apart from presbyacusis, 
hearing impairment was most pronounced at 1-2 kHz. In most family members, hearing impairment 
became apparant at about age 30, and of note, no person had clear congenital or prelingual onset of 
hearing impairment; all cases developed normal speech.
These data are consistent with the cross-sectional analysis that extrapolated onset age to not below 
age 4 years, with most significant onset ages in the range of 10-12 years. Consistent with these data, 
audiological evaluation clearly demonstrated progression in hearing impairment in two individuals 
from the age of 10 years. Audiogram shapes are best classified as showing midfrequency (1-2 kHz) 
hearing impairment, with the majority of the individuals also exhibiting a gently down-sloping 
patern. In two individuals, only the typical midfrequency hearing impairment is seen. In the 
remainder, the development of presbyacusis flattens the shape of the audiogram in the 1-8 kHz range 
with increasing age. The caloric function of the vestibular apparatus was in the majority of cases 
intact.
Most types of mid-frequency hearing impairment as classified by Konigsmark and colleagues involve 
a wider frequency range than we describe.24
1 2 7
The present family, as well as a previously described Dutch DFNA13 family, 1 show this restricted 
loss. 1 An American DFNA13 family had a congenital onset of hearing impairment.19 In these latter 
two families, missense mutations have been identified in COL11A2, and by the study of a knock-out 
mouse for COL11A2 this study concluded that COL11A2 plays an essential role in tectorial 
membrane structure and function.1 Although COL11A2 mutations are also found in the non-ocular 
Stickler syndrome and in otospondylomegaepiphyseal disease (OSMED), this mutation is the first 
mutation in a collagen gene that causes autosomal non-syndromal deafness.
Interestingly, midfrequency hearing impairment often appears to be associated with structural 
abnormalities of the tectorial membrane.
In the current family, there are no mutations in the coding region of COL11A2, suggesting that other 
genes in this region also may result in deafness at the DFNA13 locus.
As the family described in this paper shows genetic linkage to DFNA13, COL11A2 was an obvious 
candidate gene. Because COL11A2 is a very large gene comprizing 67 exons, 
mutation analysis was performed by single strand conformational polymorphism analysis. No 
mutations were detected, and there are two possible explanations for this unexpected result. First it is 
possible that a COL11A2 mutation is present in this family , and that it wasn't picked up by the 
analysis, as it is known that some mutations don't give rise to a confirmational change and a gel-shift, 
and are not picked up by this technique. Alternatively , it is also possible that no mutation is present in 
COL11A2 ,and that the hearing impairment in this family is caused by another gene located on 
chromosome 6p12. In view of the extreme genetic heterogeneity of hearing impairment this is not 
implausible and two or three deafness genes located closely together have already been reported for 
the DFNA2 locus. Which of two possibilities is correct will be resolved by future experiments.
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ABSTRACT.
A three-generation family with Saethre-Chotzen syndrome and an isolated case with the syndrome are 
presented. The proband presented with conductive hearing loss. His mother and grandmother showed 
minor features of the syndrome including conductive hearing loss.
Symptoms of the craniosynostosis syndromes can include stapes ankylosis, a fixed ossicular chain in a 
too small epitympanum, and small or even absent mastoids.
The proband was treated with a bone anchored hearing aid (BAHA) instead of reconstructive middle 
ear surgery.
Current literature on the results o f  ear surgery is reviewed. In general, reconstructive middle ear 
surgery should only be considered if congenital anomalies of the middle ear are the only presenting 
symptom. In cases with additional anomalies such as atresia of the ear canal or damage due to chronic 
ear infections, the outcome o f reconstructive surgery to correct the anomolous ossicular chain is 
unsatisfactory. In such cases the BAHA is propably a better best solution.
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INTRODUCTION.
The Norwegian psychiatrist Haakon Saethre was the first to describe a syndrome characterized by 
premature closure o f  the cranial sutures, a low-set hairline, parrot beaked nose, nasal septum 
deviation, brachydactyly, soft tissue syndactyly, defects in the vertebral column and ptosis in a mother 
and two daughters. 1 One year later Chotzen described identical malformations in a father and two 
sons. Additional findings in this family included a high arched and narrow palate, conductive hearing 
loss and cryptorchidism.2
A number of cases have since been reported under a variety of different diagnoses.3-6 Currently the 
Saethre-Chotzen syndrome is classified as type III acrocephalosyndactyly.7
The most extensive discussion of the acrocephalosyndactyly syndromes describes the Saethre- 
Chotzen syndrome as uncommon, although relatively common among the craniosynostosis 
syndromes. 8 The syndrome is transmitted as an autosomal dominant trait with full penetrance and 
great variability in expression. The responsible locus has been mapped on the long arm o f 
chromosome 7 .9
A small three generation family with the Saethre-Chotzen syndrome and one isolated case are 
presented in this report. Special attention is paid to the severity of the hearing loss in our cases and 
rehabilitation o f  their hearing. The literature on the craniosynostosis syndromes was reviewed for 
middle ear anomalies.
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CASE REPORTS.
FAMILY
The proband (Figure 1) is now a 21-year-old man. He 
was referred to the Nijmegen University Department of 
Otorhinolaryngology at the age of 17 years because of 
conductive hearing loss and chronic otitis media. Hearing 
loss was suspected from early childhood. A conventional 
hearing aid had caused chronic otorrhoea and pain 
because of pressure. Otological examination showed 
small, normally-shaped ears with a normal position and 
normal auditory canals. Both tympanic membranes 
showed retraction. The middle ear was pneumatized on 
the right, there was a glue ear on the left side. Pure tone 
audiometry revealed a conductive hearing loss of 35 dB 
on the right and 60 dB on the left. Impedance 
measurements showed a flat curve bilaterally.
(a)
premature closure of sutures a craniotomy was performed 
at the age of eight months. Later he was evaluated for a 
heart murmur, based on enlargement of a medially 
localized heart. At 11 years, he was treated for 
cryptorchidism of his left testicle.
Various early developmental milestones were reported to 
have been delayed; at the age of six years, his verbal IQ 
was equivalent to that of a developmental age of three 
years. At the age of 7 years he was transferred to a special 
school for hearing impaired children. General 
examination revealed anomalies and features of Saethre- 
Chotzen syndrome. (Figure 2)
(a)
Figure 2.
Some characteristics of the proband; dental spacing with 
anomalous lateral inscisors. (a) Soft tissue syndactyly of 
the 2nd and 3rd fingers, (b)
(b)
Figure 1.
Mother(a) and proband (b) with the typical 
appearances of Saethre-Chotzen.
Syndromal hearing loss
soft tissue syndactyly of the 4th and 5th toes with 
valgus position of a broad first toe. (c)
He is the only child of unrelated parents. He was treated 
for neonatal seizures until the age of one year. Because of
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(c)
Computed tomography (CT) scanning of the petrosal 
bones revealed a normal configuration of the inner and 
middle ear structures. Pneumatisation was markedly 
reduced due to under development of the mastoids. Due 
to the small mastoids, presumed epitympanic fixation, 
lack of well-aereated middle ears and recurrent ear 
infections, known from literature to be present in various 
craniosynostosis syndromes; it was decided not to 
perform a exploratory tympanotomy.
His conventional hearing aid was replaced by a left sided 
bone anchored hearing aid (BAHA) to rehabilitate his 
hearing. Hearing improved post-operatively with a 
functional gain to approximately an aided PTA of 25 dB 
for his left ear.
His 43-year-old mother (Figure 1a) was found to show 
minor features of the Saethre-Chotzen syndrome; small, 
non-dysplastic ears with normal implant and minimal 
atresia of the right external auditory canal are present. 
Her audiogram showed pure conductive hearing loss with 
a pure tone average (PTA) of 35 dB bilaterally. An 
audiogram of the proband's 65-year-old grandmother 
revealed pure perceptive hearing loss with a PTA of 25 
dB bilaterally. Mild characteristics of the Saethre- 
Chotzen syndrome were found at general physical 
examination. (Figure 3)
The mother of the proband is the only child of unrelated 
parents. Her maternal uncle was not reported to exhibit 
any visible signs of Saethre- 
Chotzen syndrome but was not examined.
(a)
Figure 3.
Grandmother with Saethre-Chotzen syndrome (a) and 
skull X-ray showing variations in bone density which is 
typical o f the craniosynostosis syndromes (b).
(b)
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ISOLATED CASE.
A 23-year-old woman with the Saethre-Chotzen 
syndrome presented with bilateral flat conductive hearing 
loss of 45 dB on the right and 30 dB on 
the left ear. There was bilateral congenital atresia of the 
external auditory canal type IIa.
Characteristics of the Saethre-Chotzen syndrome were 
present. Findings of CT scanning are shown in Figure 4. 
Surgery was performed on the right ear to create a new 
auditory canal and tympanic membrane. This ear was 
selected for surgery because it had the most severe 
hearing loss.
However, asymmetrical underdevelopment of the petrous 
bones was more pronounced on this side and was 
considered to form a disadvantage for successfull 
surgery. After removal of the bony plate, causing malleus 
fixation, the ossicular chain was found to be intact. The 
hearing level on the right side improved from 45 dB to 
30 dB.
Figure 4.
CT scanning of the petrosal bones in isolated case: 
marked asymmetry with reduced pneumatization of the 
right petrous bone.(left in figure)
Chapter 4
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DISCUSSION.
Table I summarizes the main characteristics in the family and in the isolated case with the Saethre 
Chotzen syndrome. Table II shows a summary of the specific middle ear anomalies in the Saethre- 
Chotzen, Apert, Crouzon and Pfeiffer syndromes reported in literature.
In Saethre-Chotzen syndrome non-specified hearing loss has been reported.1,10,11,12 The largest serie 
reported conductive hearing loss in 15 percent but mixed hearing loss has also been mentioned. 8,13 
Hearing loss in the Apert syndrome was exclusively of a conductive nature. Middle ear effusion was 
present in the majority of investigated ears.14-16 A primary anatomical malformation was noted 
infrequently in Apert syndrome by polytomography. Hearing loss in the Apert syndrome was 
primarily caused by altered nasopharyngeal anatomy.17 It can be compared to otopathology in cleft 
palate, although in the Apert syndrome there is no resolution with age.
Large studies on the Crouzon syndrome have estimated that the incidence of conductive hearing loss 
is 55 percent but pure sensorineural hearing loss has also been described. Middle ear effusion is less 
frequent.16-18
In one case with the Crouzon syndrome a second stage procedure was necessary after endaural 
widening epitympanotomy had resulted in refixation of the ossicular chain in the epitympanum. 19 In 
another case stapedectomy improved the patients hearing.20
In the Pfeiffer syndrome conductive hearing loss, and ossicular chain anomalies have been 
described.21 In a mother and son with a rare craniosynostosis syndrome, pure conductive hearing loss 
and pure sensorineural hearing loss were described that involved the low and middle frequencies.22 
The most frequently encountered inherited syndromes with craniosynostosis are the Apert, Crouzon, 
Pfeiffer and Saethre-Chotzen syndromes. All have an autosomal dominant pattern o f  inheritance.
The physical findings in our proband closely resembled those in the original descriptions by Saethre 
and Chotzen. The proband, his mother and grandmother demonstrate aggrevated and more 
pronounced features present in next generations o f  this dominant inherited condition.
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Table 1: Features present in the Saethre-Chotzen syndrome
Findings Pantke case I case II case III case IV
Low set frontal hairline + o - +
Acrocephaly >75% + + + +
Nasal septum deviation + + * o
Ptosis of eyelids + + + +
Parrot- beaked nose o + + +
Brachydactyly + + + +
Low set ears 50-70% - - - -
Tear duct stenosis - - - -
Strabismus - - - -
Facial asymmetry + + - +
High arched palate - - + *
Spinal anomalies 25-50% + * * -
Dystopia cantorum + - - -
An.Lat.incisors + * * -
Hypertelorism - - - -
Impaired hearing + + + +
Optic atrophy * * * *
Tissue syndactyly 25% + + - +
Clinodactyly + + * -
Cleft palate * - - -
Cryptorchidism +
Heart murmur + * * -
Renal anomalies 0-25% + * * *
Imperforate anus - - - -
Mental retardation o - - -
+ = present; o = moderate ; - = absent; * == unknown.
Table II: Findings and results of exploratory epitympanotomies in craniosynostosis syndromes
Author/Syndrome Sex/age Ear Hearing loss Malleus/Incus/Stapes Surgery Hearing gain
Marini13 M/2yr L Mixed Short Unknown Moderate
Saethre Chotzen R Mixed Short sensorineural component
Bergstrom14 F/17 yr L 50dB cond Fixed footplate Teflon prothesis None, slipped prothesis
Apert R 40dB cond
Philips77 M/27 yr L 30dB cond Deformed malleus(bil) Stapes mobilisation Unknown
Apert R 30dB cond Thickened footplate(bil)
Philips m/6yr L 40dB cond Fixed incus Incus removed Minimal
Apert R 50dB cond Homograft malleus on
stapes capitulum
Cremers19 f/13yr L 55dB cond Epitympanic fixed Epitympanotomy 15 dB
Crouzon R none malleus,incus
Boedts 20 m/38yr L 70 dB mixed Shea piston 40db
Crouzon R 20 dB cond
Cremers21 m/14 yr L 45 dB cond Ankylotic malformed Stapedectomy 30dB
Pfeiffer Incus and stapes _
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The literature describes 16 families diagnosed as having the Saethre-Chotzen syndrome and some 
sporadic cases.23
Typical congenital anomalies of the middle ear in the cranio-synostosis syndromes include fixation of 
the ossicular chain in a small epitympanum and ankylosis of the stapes. Bony meatal atresia can also 
be present and in most cases the mastoid is small. Ventilation of the middle ear seems to be impaired 
because of Eustachian tube dysfunction. Few results of ear surgery have been published on patients 
with craniosynostosis syndromes. 19-21
In this report three additional cases of the Saethre-Chotzen syndrome and an isolated case are 
described. All of them had conductive hearing loss. The two oldest patients could be managed 
satisfactorily with a conventional hearing aid. In the proband reconstruction of the ossicular chain 
combined with stapes surgery was not performed mainly due to the combination of a small mastoid 
and recurrent ear infections. He proved to be a good candidate for a BAHA because he was unable to 
wear an air conduction hearing aid.
If surgical intervention is considered to be an option for patients with craniosynostosis and fixation of 
the ossicular chain in the epitympanum and oval window has occurred, it may be possible to remove 
the incus and the head of the malleus and then perform a stapedectomy procedure by fixing the piston 
to the malleus handle. This procedure would mean that refixation of the ossicular chain in the 
epitympanum is no longer necessary.
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ABSTRACT.
An inherited middle ear anomaly that was causing hearing impairment in a 12- year-old girl was 
treated successfully by a stapedotomy combined with a malleo-vestibulopexy. Cup shaped ears, 
abnormal or absent thumbs and skeletal deformities of the forearms were present in several members 
of 3 generations of a family. An autosomal dominant pattern of inheritance was recognized. These 
features are present in a number of previously described syndromes, but they correspond best with the 
lacrimoauriculodentodigital syndrome.1
INTRODUCTION.
In about one third of patients with congenital conductive hearing loss, the hearing loss is part of a 
syndrome. About 50 genetic syndromes with congenital conductive hearing loss as a feature have 
been reported. The lacrimoauriculodentodigital (LADD) syndrome is new to this list. LADD 
syndrome is listed as a seperate entity by McKusick.1 An autosomal dominant pattern of inheritance 
was recognized. In most cases of LADD syndrome the hearing loss is pure sensorineural. In the case 
reported herein, the hearing loss is congenital in origin and of the conductive type. Reconstructive 
surgery of the ossicular chain proved to be succesfull.
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An 12-year-old girl (Figure 1) was referred for 
reconstructive middle ear surgery. Exploratory 
tympanotomy had been performed on the left side when 
the patient was 5 years old. At that time, a dysplastic 
incus body was removed; there was no stapes 
superstructure and the stapes footplate was ankylotic. 
Bilateral dysplasia of the superior helices was corrected 
at that time.
REPORT OF A CASE.
Figure 1.
A 12year old girl with the Lacrimo-auriculodentodigital 
syndrome (LADD) and unilateral congenital conductive 
hearing loss.
Otologic examination showed normal tympanic 
membranes. The auricles were smaller than normal
(Figure 2).
Figure 2.
Auricles of the proband. Note the scar from 
auriculoplasty.
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Interdentate spacing in the upper and lower arches was 
abnormal. The small permanent incisors had the 
appearance of deciduous teeth. Although the enamel of 
all the teeth was thin, premature decay had not occurred. 
No third molar teeth were present. The hard and soft 
palates were normally fused, with no clefts.
The left thumb was hypoplastic and digit-like; flexion 
was restricted. The left thenar eminence was hypoplastic. 
(Figure 3)
Figure 3.
Anomalies of the thumb, with a digit like aspect of the left 
thumb.
Radiographs of the hands and feet were normal. 
Ophthalmological examination was also normal; 
dacrostenosis was absent and all lacrimal punctae were 
present.
Audiometry indicated flat air conduction thresholds of 60 
dB in the left ear and of 20 dB in the right ear with absent 
ipsilateral and contralateral stapedial reflexes. (Figure 4) 
Middle ear compliance and pressure were normal. 
Computed tomographic scanning of the petrosal bones 
demonstrated normal inner ear structures.
A number of members of the proband's family had similar 
characteristics. The proband's mother had a left-sided 
facial asymmetry. Both helices had been corrected. 
Thumbs and fingers were normal and function was 
unimpaired. Supination at the elbows was reduced. Age 
related bilateral flat sensorineural hearing loss was 
present. The proband's sister was normal. Investigation of 
a maternal uncle demonstrated dysplasia of both
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Figure 4.
Pure tone audiograms obtainedpre-operatively (top) and 
5 years after malleo-vestibulopexy.
auricles, slight hypoplasia of the left shoulder 
musculature and hypoplasia of both forearms and hands 
that was more severe on the left side. The left thumb was 
missing, while the right thumb and index finger were 
hypoplastic. Radiographs of the forearms showed 
bilateral short forearm bones more marked on the left, 
with hypoplasia of the olecranon, coronoid process, ulna 
and the head of the radius. Synostosis of the trapezium, 
trapezoid, capitate and pisiform bones in both hands had 
occurred. Audiometric data were not available, but his 
hearing was reported to be normal. The probands 
grandfather was reported to have had cup shaped ears and 
had never been able to extend his thumbs. Precise history 
about hearing function
lcV ? T f e a f at tl,e- age  #  12 years, .?!iglu ,lixation in the
epitympanum, of,the ■ ffial^eus head was found. The incus 
was removed during the previously performed surgery. 
Stapes footplate ankylosis was reconfirmed. The malleus 
head was removed and the tympanic membrane was 
stripped from the proximal one third of the long process 
of the malleus. Stapedotomy was performed on the 
footplate of the stapes and a 0.4 mm Teflon platinum 
piston (Richard Co, Memphis, Tenn ) with a length of 
4,75 mm was used to perform a malleo-vestibulopexy. 
The piston eye was fixed around the proximal part of the 
malleus handle which had been partly stripped of the 
tympanic membrane.
Post-operative results indicated improvement in the 
conductive threshold from 60 dB pre-operatively to 20 
dB postoperatively with a 5 year follow up. (Figure 4)
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DISCUSSION.
The features observed in the present family correspond most closely to the report by Hollister of a 2 
generation of a family who had cup-shaped ears, mixed hearing loss and nasolacrimal duct 
obstruction, and an isolated case described by Levy diagnosed as LADD syndrome. This syndrome is 
now listed as a separate entity in Mc Kusick's catalogue.1-3
Syndromes with an autosomal recessive pattern of inheritance, cup-shaped ears and middle ear 
anomalies were not considered to apply to our patient. 4-6
Syndromes with an autosomal dominant pattern of inheritance, (e.g. the branchio-oto-renal) syndrome 
could also be excluded from the differential diagnosis because although cup shaped ears were present 
there were no branchial fistulas and pre-auricular sinuses.7 In a similar syndrome, cup-shaped ears, 
commissural lip pits and ear pits are present, but skeletal abnormalities have never been reported.8 
The hand anomaly observed in the proband did not resemble ectrodactyly and none of the subjects 
had a cleft lip and palate as is present in the ectrodactyly-ectodermal dysplasia clefting syndrome.9 
Another syndrome is characterized by radial ray aplasia, mixed or sensorineural hearing loss, external 
ophthalmoplegia and thrombocytopenia. Skeletal abnormalities are more severe and cup dysplasia is 
absent.10
After the first description of LADD syndrome similar observations have been described by several 
authors. 2,3,11-13 Limb malformations are the most common feature but they are also highly variable. 
Teeth are often discolored and enamel thinning occurs. Premature decay leads to the loss of 
permanent teeth often before adolescence. Various salivary gland anomalies have also been described, 
leading to xerostomia which enhances tooth decay. Cup-shaped ears are mentioned consistently and 
are usually more obvious than the hearing loss. Other features such as weeping eyes caused by 
blockage of tear ducts, are also noticeable.
The incidence of hearing loss described in reports of the LADD syndrome is approximately 50%. In 
most cases, it consists of mild to severe, predominantly sensorineural hearing loss.
This case of middle ear anomalies, in association with the LADD syndrome, was treated by 
reconstructive middle ear surgery. To perform a malleo-vestibulopexy it is helpful to extend the upper 
part of the Rosen incision in an anterosuperior direction to achieve wider exposure of the malleus. 
The malleus head is then removed and the upper one third
of the malleus is stripped of the tympanic membrane. The malleus handle is kept in position by the 
remaining anterior ligament. These procedures facilitate the crimping of the eye of a Teflon platinum 
piston, although the malleus is in a much more anterior position than the normal anatomical position
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of the incus. In congenital middle ear anomalies, the external auditory canal may be more curved than 
normal so that the anterior canal wall limits the surgical approach to the malleus. Reconstruction of 
the middle ear chain by a Teflon platinum malleus attachment prothesis can help to overcome such 
anatomical limitations.
Only a few reports of this procedure in cases of a missing incus and stapes arch have been published. 
Long term results show closure of the pure-tone average air-bone gap to within 10 dB in 70% of all 
individuals. Best results were reported in congenital chain defects. 14 Our case, with a 5 yrs follow- 
up, illustrates a satisfactory outcome with this technique.
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ABSTRACT.
Two brothers with congenital conductive hearing loss and phenotypic characteristics of maxillofacial 
dysostosis are described. In the oldest boy a malformed ossicular chain was present and the 
conductive hearing loss was improved by a malleo-vestibulo-pexy, with post-operative hearing gain of 
approximately 30 dB.
Although similar to Treacher Collins syndrome, the facial characteristics are more typical of 
maxillofacial than of mandibulofacial dysostosis. These cases most likely represent a new type of 
maxillofacial dysostosis inherited as an X-linked or autosomal recessive trait.
INTRODUCTION.
Many distinct inherited syndromes have been described that originate from branchial arch defects.1 
Midface hypoplasia, pre-auricular tags, fistulae, microtia, and cleft lip or cleft palate, are typical 
features of these branchiogenic syndromes.
The most common of these are mandibulofacial dysostosis or the Treacher Collins syndrome and the 
Goldenhar or oculoauriculo-vertebral syndrome.
A much rarer branchial arch syndrome was first described by Toriello and is characterized by 
intellectual dysfunction, microcephaly, short stature, protruding ears, midface hypoplasia, a high 
arched palate and an X-linked pattern of inheritance. 2
We report two brothers who share several anomalies with the Toriello branchial arch syndrome. 
Maxillary hypoplasia was their most striking characteristic. However both had normal stature and 
intelligence.
The pattern of inheritance in this family with two boys is either X-linked or autosomal recessive. 
Other reports on maxillofacial dysostosis suggest autosomal dominant inheritance. The syndrome 
described here thus represents a new type of maxillofacial dysosotosis of either X-linked or autosomal 
recessive inheritance.
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The index case, the first child of non-consanguineous 
parents, was born after an uneventful pregnancy with 
bilateral cleft lip and cleft palate. Bilateral pre-auricular 
fistulae were corrected surgically shortly after birth. 
Hearing impairment was suspected at a young age; his 
language skills were poorly developed. Conductive 
hearing loss of 55 dB in both ears was confirmed 
audiometricallly at four years of age. The external 
auditory canals were narrow. The boy also had small low 
set ears, a broad nasal bridge, malar and maxillary 
hypoplasia and hypoplastic zygomatic bones. A 
retroganthia is clearly present (Figure 1).
CASE REPORTS.
(a)
A diagnosis of the Treacher Collins syndrome was 
considered at that time. Midface hypoplasia was 
corrected at the age of 15 years. On examination at the 
age of 18 years, he was 162 cm tall (<P3) with a weight of 
54 kg (P10) and an occipital frontal circumference (OFC) 
of 54.2 cm (P25). Inter canthal distance (ICD) was 34 mm 
(P75); outer canthal distance (OCD) was 92 mm (P50-75). 
Common signs of branchial arch syndromes such as 
antimongoloid slanting; colobomas and epibulbair 
dermoid of the eyes were absent. Visual acuity was 
normal. No cervical spine anomalies were present and 
there were no anomalies of the extremities. Cognitive 
development is normal.
Exploratory tympanotomy revealed a monopodal stapes 
with no head and no incudial corpus. The malleus head 
and stapedial footplate were removed and the upper one 
third of the malleus handle was stripped away from the 
tympanic membrane. A 5 mm Teflon-Platinum piston 
was fixed around the malleus handle and a vestibulo- 
malleopexy was performed. Post-operative hearing 
improved to a conductive threshold of approximately 30 
dB, which was maintained at a follow- up of 3 years.
The younger brother of the propositus was born with 
similar facial characteristics: low set dysplastic ears, 
bilateral pre-auricular fistulae, retrognathia and malar 
hypoplasia. Ptosis of the left upper eyelid was present 
(Figure 2).
(b)
Figure 1.
Facial appearance index case at 11 years (a);
note the maxillary hypoplasia and facial appearance
after zygoma osteotomy at the age of 18 yrs (b)
(a)
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No anomalies of the extremities were found. Intellectual 
development is normal.
At the age of four years his receptive language skills were 
mildly delayed while his expressive language 
development was delayed by 1 1/2 years. Non­
progressive bilateral conductive hearing loss with a 
conductive threshold of 40 dB was documented and has 
remained constant up to the age of 15 years. Exploratory 
tympanotomy has not been performed. Neither the boys 
parents nor any other family member showed any of the 
above described anomalies. A study for gene linkage was 
refused.
(b)
Figure 2.
Facial appearance of the probands younger brother at 
the age of 12yrs (a); and after zygoma-osteotomy at the 
age of 17 years; note the ptosis of the left eye (b)
Colobomas and epibulbar dermoid were not found. There 
was no facial clefting. Midface hypoplasia was corrected 
at the age of 15 years. Stature was within normal limits.
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DISCUSSION.
The facial characteristics in these boys only vaguely resemble mandibulofacial dysostosis (Treacher 
Collins syndrome) . 1,3 Facial characteristics of Treacher Collins syndrome comprise mandibular 
hypoplasia; anti-mongoloid and downward slanting of palpebral fissures as well as coloboma of the 
lower eyelids. Also there is absence of medially localized cilia. A cleft lip-palate seen in our index 
case and ptosis of the upper eye lid which was present in the younger brother, are rare in this 
syndrome. Moreover the Treacher Collins syndrome has autosomal dominant inheritance. However, 
rare recessive forms of mandibulofacial dysostosis have been reported sofar with a predominance in 
males.4-7 Also non-penetrance of Treacher Collins syndrome has been reported. 8 
Clinically a syndrome with dysostosis of the maxilla as most prominent feature is considered more 
likely. In many ways these boys also resemble the description by Lowry although the phenotypical 
characteristics are more severe in this family.5
The earliest description of inherited maxillary hypoplasia originates from 1932 and concerns an 
affected grandfather, father and son. The autosomal dominant pattern of inheritance of maxillofacial 
dysostosis was confirmed and the phenotype was delineated as a distinct syndrome.9 As minimal 
diagnostic criteria for maxillofacial dysostosis presence of anterior-posterior shortening of the 
maxilla; anti-mongoloid slanting of the palpebral fissures and often nonfluent and inarticulate speech 
with normal intelligence and hearing was proposed.10,11 Another, possible mild example of autosomal 
dominant maxillofacial dysosotosis was described by Kawashima and Tsuji.12
Since both parents are clinically normal and the lack of other apparantly affected family members, a 
autosomal recessive pattern or X-linked pattern of inheritance is considered more likely. The delayed 
speech development in the youngest was probably the result of hearing impairment. X-linked 
inheritance would be consistent with the Toriello variant of maxillofacial dysostosis.13,14 However, 
normal intelligence in these boys are not in accordance with Toriello syndrome. Cryptorchidism and 
sub-valvular pulmonic stenosis both of which have been described in Toriello syndrome were not seen 
in our cases.
The low set protruding ears and the mild short stature, and the maxillary hypoplasia described in 
Toriello syndrome were present in our cases. In the Goldenhar syndrome epibulbar dermoids, cervical 
spine anomalies and facial asymmetry are frequently present
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but these were absent in the cases reported here.15 The combination of especially preauricular pits and 
abnormal pinnae might suggest a diagnosis of branchio-oto-renal (BOR) syndrome but cervical 
fistulae were absent. Moreover, maxillary hypoplasia is not a feature of the BOR syndrome. 16 
Differential diagnostic considerations are summarized in Table 1.
TABLE 1. 
Characteristic findings in branchial arch syndromes
Case 1 Case 2 Treacher Collins Toriello syndrome Maxillofacial dysostosis
Pre-auric. fistules 
Small low set ears 
Cleft lip-palate
Pre-auric. fistules 
Small low set ears 
Ptosis left eye
Malformed pinnaMicrocephaly 
Supra-orbital rim Low set ears
AP shortening maxilla 
Malformations auricles
Max. hypoplasia Max. hypoplasia Narrow face 
Hearing loss Hearing loss
Normal IQ Normal IQ
Normal parents Normal parents Aut. dominant
hypoplasia
Webbed neck 
Hearing loss 
Normal IQ 
Eye lid colobomata 
Deficiency cilia 
Receding chin
X-linked 
(variabel expressivity)
Pre-auricular pits
Inarticulate speech
Hearing loss 
Mental retardation 
Short stature 
Cryptorchidism 
Sub-valv pulm sten.
Autosomal dominant
No hearing loss 
Normal IQ
The Treacher Collins syndrome is the brachial arch syndrome in which middle ear anomalies are best 
documented.8 Approximately 50% of patients have conductive hearing loss. Middle ear anomalies are 
mostly complex and are rarely amandable to reconstructive surgery. The presence of a malleus handle 
in the oldest index case made it possible to perform a malleo-vestibulopexy; as this middle ear 
surgery procedure has good post-operative results in the majority of cases.17
In summary we present a new form of maxillofacial dysostosis in which autosomal dominant 
inheritance is unlikely. Recognition of these clinical patterns of anomalies has important implications 
for individual patient counselling. Further reports are needed to clarify whether this form of 
maxillofacial dysostosis is inherited as an autosomal or X-linked recessive trait.
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ABSTRACT.
A 26-year-old woman is described with a bilateral congenital conductive hearing loss as a result of 
bilateral stapes ankylosis. Today this syndrome is listed as separate clinical entity in Mc Kusicks
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catalogue.1 (18580) It is one of about 50 genetic syndromes with congenital conductive hearing 
impairment mentioned in the literature.
Middle ear reconstruction to treat bilateral conductive hearing loss of approximately 60 dB was 
successfull in both ears, with complete closure of the air-bone gaps.
The follow-up of previous and additional ear surgery in two Dutch brothers is also reported.11 A 
summary is made of the results of ear surgery in this syndrome.
INTRODUCTION.
Symphalangism was first delineated as a hereditary malformation of the proximal interphalangeal 
(PIP) joints by Harvey Cushing in 1916.2 He described a family, spanning 7 generations, previously 
thought to be related to the first Earl of Shrewsbury, John Talbot, who was mentioned in 
Shakespeare’s Henry VI. Symphalangism was therefore also known as “Talbot fingers”. The 
characteristic finger deformity was confirmed when his grave was opened in 1874.3 
Follow-up of the original Talbot family later on, demonstrated many individuals with conductive 
hearing loss with early onset.4 Vessel was the first to demonstrate the presence of conductive hearing 
loss associated with symphalangism.5 Since then it has been assumed that symphalangism and 
conductive hearing loss are associated with the same gene. Several reports confirmed this 
association.6-11 Some authors have reported on an association with strabismus.51112 
Recently, Polymeropoulos has demonstrated linkage to 17q21-q22 in this historic kindred.13 
We report on similar associations of symphalangism and conductive hearing loss in two families. 
Follow-up of hearing and additional revision tympanotomy findings in a previously-reported family 
are also discussed. 11
A summary is made of otological manifestions and middle ear surgery results in this rare syndrome.
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REPORT ON TWO FAMILIES AND THE 
RESULTS OF SURGERY.
BELGIAN FAMILY.
A 26 year-old Belgian woman (Figure 1) was referred to 
one of the authors (JS) at the age of 20 years. Stable and 
non-progressive hearing loss had been present since 
birth. Pregnancy and delivery were said to have been 
uneventful and there were no accompanying reasons for 
hearing loss.
Initially, the present diagnosis was missed.
(a)
Figure 1.
Facial (a) and hand characteristics (b) in the index case.
(b)
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Retrospectively, complaints of stiff fingers had been 
present in the index case as well as in her mother and 
maternal grand-mother. Foot problems had been 
corrected at a young age, but never documented. 
Radiographs disclosed luno-triquetral synostosis and 
capito-hametal synostosis of both hands and deformities 
of the right scaphoid bone. The proximal and middle 
phalanx of the fourth and fifth fingers were fused. 
(Figure 2).
Figure 2.
Radiographs of the probands hands: The proximal and 
middle phalanx of the fourth and fifth fingers are fused.
Otoscopy showed normal tympanic membranes. Pre­
operative audiometric examination disclosed 
asymmetrical conductive hearing loss of 55 dB in the left 
ear with absent stapedial reflexes (Figure 3 top). This ear 
was explored surgically and stapes ankylosis was found. 
No abnormalities of the stapes and supra-structure were 
encountered. Stapedotomy was performed successfully 
with preservation of the chorda tympani. A Teflon piston 
with a length of 4.5 mm was placed to
reconstruct the mobility of the ossicular chain. One year 
later, a similar procedure was performed 
on the the right ear to treat a 40 dB conductive hearing 
loss. Again stapes ankylosis was found.
At the time of this tympanotomy of the right ear, 
impaired bending function of the right index finger was
161
noticed and also inability to make a fist. The length of the 
forearms and fingers were normal. Blepharophimosis 
was present. (Figure 1) , although, no concomitant 
anomalies of facio-audiosymphalangism were found such 
as short fingers and habitual radial head luxation. Elbow 
functions were normal.16
A syndromal diagnosis of proximal symphalangism with 
conductive hearing loss was most likely. Similar fusion 
of the phalanges, limited to only the fourth fingers, were 
found in the mother and the maternal grandmother. 
Hearing was reported
an unilateral air-bone gap of 50 dB.(right ear) Revision 
surgery was performed on this ear 8 months after the 
initial surgery. The short process of the incus was fixed to 
the surrounding bone in the fossae incudis.
Figure 3.
Pre-operative audiogram of the left and right ears (top) 
and post-operative audiograms ( bottom) after middle 
ear surgery anf follow up of 2 years (Belgian case)
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to be only impaired in the grandmother. 
strabismus were absent.
Myopia and
DUTCH FAMILY.
The syndromal features of both affected sons and their 
father (Figure 4) were reported previously. In the oldest 
son a stapedotomy on the right ear with a Teflon 
platinum piston was performed for a pre-operative 40 dB 
conductive hearing loss. Follow-up of hearing disclosed
The fixing bone was removed. A new Teflon piston (5 
mm;0.4 mm diameter) was placed. Hearing improved to 
a 10- 20 dB hearing level with an air-bone gap of 10-20 
dB PTA Fletcher (0.5; 1;2 kHz) index. Approximately 8 
years later the left ear with a similar pre-operative air- 
bone gap was explored. A stapes ankylosis and 
congenital fixation of the short process of the incus in the 
fossa incudis were found. The fossa incudis was opened 
to achieve a mobile incus. Stapedotomy could be 
performed leaving the footplate in place. A Teflon- 
platinum piston with a 0.4 mm diameter (shaft length 4.5 
mm) was placed. A mixed hearing loss of 20-30 dB was
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present post-operatively. However the hearing loss 
increased within 2 years to a 60 dB air-bone gap at all 
frequencies. Besides the hearing deterioration in the left 
ear, the hearing level in the right ear deteriorated after 6 
years to 50 dB flat hearing loss with an almost 50 dB air- 
bone gap.
One year post-operatively the sensorineural hearing level 
in the left ear increased gradually mainly for 2-8 kHz to 
60 dB. A peri-lymph fistula was suspected, so the left ear 
was re-explored. A dislocated piston was found without 
any renewed incus fixation. The opening in the footplate 
was closed by a membrane. A 5 mm long, 0.4 mm 
diameter teflon-platinum piston was placed. An overall 
hearing gain of 20 dB was achieved found with follow-up 
of 4 years (left ear).
Exploratory tympanotomy (right ear) on the younger 
brother who had unilateral right-sided congenital 
conductive hearing loss showed congenital stapes 
ankylosis. (pre-operative 50 db conductive hearing loss). 
The facial nerve was not covered by bone at the side of 
the oval window. The retro-auricular approach showed 
diminished mobility of the short process of the incus in 
the fossa incudis. The epitympanum was found to be 
narrow without any fixation of the malleus or incus. 
Stapedotomy was performed; a 0.4 mm and 5mm long 
teflon platinum-piston was placed. Only 20 dB 
improvement was achieved and an air-bone gap of 30 dB 
remained, which increased to 60 dB air-bone gap over 5 
years of follow-up. Re-exploration disclosed normal 
mobility of the incus; the piston was not attached to the 
long process of
The incus and the stapedotomy was closed by new bone. 
Small scale stapedotomy was performed.
(new piston : 0.4mm; 5.25 mm)
Figure 4.
Characteristic inability to make a fist in the father of the 
Dutch family.
Syndromal hearing loss
The hearing level improved from a flat 60 dB level to a 
30 dB flat hearing level with a 20 dB air-bone gap at a 
one year follow-up. A revision stapedotomy (third 
exploratory tympanotomy, pre-operative air-bone gap 38 
dB) was performed in which renewed bony growth was 
found at the footplate. A longer piston was placed (5.75 
mm) The post-operative air bone gap , with a two years 
follow-up was narrowed to 10 dB.
163
RESULTS OF EAR SURGERY FOR THE 
PROXIMAL SYMPHALANGISM SYNDROME.
Table I  lists the results of surgery in 14 ears from 7 patients, including the stapedotomy in the right 
ear of the first Dutch patient. We have added the findings and results of revision ear surgery in four 
new ears.(2 Dutch; 2 Belgian) Until now only good results have been mentioned after stapes 
replacement surgery for this syndrome. However, the results might deteriorate over 5 years of follow- 
up.
DISCUSSION.
The main characteristics of proximal symphalangism comprise proximal fusion of interphalangeal 
joints of the fingers and tarsal and carpal bone fusions with a conductive hearing loss. The pattern of 
inheritance is autosomal dominant.
In most cases intra-familiary variation in prevalence of hearing loss and fusion of the fingers and toes 
occurs. Towards adolescence, the hands tend to show the clinical halmarks of complete bony fusion. 
The thumb and metacarpophalangeal joints are usually not involved. Malsegmentation of the triquetral 
bone and fusion of the lunate and hamate bones occur frequently, while the talar and navicular bones 
might be fused. In some typical cases, this results in a typical duck-like gait.15 The association of 
symphalangism and conductive hearing loss is also present in facio-audiosymphangalism. A long nose 
with minimal alar flare and characteristic anomalies of the extremities such as short fingers and upper 
arms with limited function at the elbows, are most common in this syndrome.14,16 Although the 
symptoms in the first case were typical, this syndrome was not considered.
Histological reports on the resected stapes vary from an abnormal bony bridge between the crura and 
footplate 12 ; local bony fusion of the stapes footplate with thickened bone in the oval window niche 10 
, to abnormal ossification in the vestibular area of the footplate and calcification of the annular 
ligament.7 In the Dutch family the posterior part of the footplate was thickened and the lateral part of 
the annular ligament was fractured due to bony fixation in the oval window niche. 11 In the literature of 
the proximal symphalangism most reported anomalies are limited to the stapes only. An elongated 
long process of the
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incus and bony fixation of the short process of the incus were also mentioned. 8,11 Exceptional findings 
were fixation of the incus in the three ears of the two brothers and recurrent bony closure of the
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footplate after stapedotomy in the right ear of the youngest brother. Luxation of the piston from the 
oval window occurred in all three ears. However, it is unclear whether the piston dislocated because it 
was relatively short. Another reason could be a regrowth of bone at the footplate causing extrusion. 
This could be a consideration, in this syndrome, to perform a partial platinectomy or total 
stapedectomy in stead of a stapedotomy technique.
The results of ossicular chain reconstruction are good and even in a few cases a complete closure of 
the air bone gap has been reported. 7-11 In all cases the onset age of hearing impairment was before the 
age of nine years. The hearing level and the air-bone gap in the operated ears was between 40 to 60 
dB, which reflects complete fixation of the footplate (Table I). The sensorineural component 
developped in the left ear is considered to be the result of a temporary perilymph fistula what was 
closed by nature after a short time.
The results of surgery in the Belgian patient are in agreement with those reported in the literature. 
Those in the two Dutch two brothers are disappointing and deviate from the long-term Nijmegen 
results for congenital stapes ankylosis.
CONCLUSION.
Good results can be achieved with reconstructive surgery for stapes ankylosis in the proximal 
symphalangism syndrome. The congenital conductive hearing loss was mainly the result of stapes 
ankylosis. Partial platinectomy might be considered to prevent reclosure of the oval window. In some 
cases, hidden fixation of the short process of the incus was observed. A fixed short process of the 
incus is very uncommon and it was even more striking to encouter it in the three ears of the two 
brothers affected by this syndrome. The disappointing long term results of stapes surgery can be 
attributed to the piston being relatively too short. Bony closure of the stapedotomy opening may have 
also played a contributing role.
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Author Ear Hearing impairment Middle ear findings Middle ear construction Follow- up hearing level
(pre-operative) Post-operative air bone gap
Table 1: Summary of otological aspects reported with proximal symphalangism and conductive hearing loss
Vase8 both ears 60 dB conductive
GoriinI0both ears 40 dB conductive
Ueda7 both ears 65 dB conductive
right ear 70 dB conductive
GIoede12both ears 60 dB conductive
Elongated crus longum incudis 
Fixed deformed stapes both ears
Fixed stapes; persisting stapedial 
artery both ears
Normal stapes; bony fixed 
footplate both ears
Normal stapes;bony fixed footplate 
calcified annular ligament
Abnormal bony bridge and footplate
House stapedectomy both ears
Stapedectomy;wire prothesis
Stapedectomy, removed crura 
Polytef wire piston
Stapedotomy 
Stapedectomy both ears
5 dB both ears 
(10 dB sensorineural)
10 dB both ears 
(5 dB sensorineural)
0 dB both ears 
(20 dB sensorineural)
10 dB 
(30 dB sensorineural)
20 dB (10 dB sensorineural)
This report
Dutch case I 
Right
Belgian case 
left
right
Case 1 left 
Dutch case
Case 1 left
Case 2 right 
Dutch case
40-50 dB conductive
55 dB conductive 
40 dB conductive
40 dB conductive
80 dB mixed
50 dB conductive
80 dB mixed
Bony fixation short proces incus 
Revisional surgery
Bony stapes ankylosis
Bony stapes ankylosis
Stapes ankylosis
Fixed short process of the incus
Revision surgery: no fixation 
Mobile incus; dislocated piston 
Footplate covered by membrane
Stapes ankylosis
Fixed stapes process of the incus
VII nerve uncovered
Revision stapes surgery
(twice) Renewed bony growth 
at footplate
Opening fossa incudis 
Teflon piston
Total stapedectomy 
teflon interposition 
Total stapedectomy 
teflon interposition
Stapedotomy 
Teflon piston
Teflon piston 
0.5 mm longer
Stapedotomy
opening fossa incudis
0,4 mm teflon platinum piston
0,5 mm longer 0,4 mm teflon 
Platinum piston, small scale 
stapedotomy
20 dB
0
(15 dB sensorineural)
0 dB
(10 dB sensorineural)
25 dB (1 year follow-up)
(10 dB sensorineural)
50 dB (2 year follow-up)
Increasing (4 year follow-up)
Unexplained large high tone sensorineural component 
60 dB (4 years follow-up)
(20 dB airbone-gap)
30 dB (10-25 dB AB-gap)
30 dB (15 dB AB-gap)
with closure air-bone gap in third
exploratory tympanotomy to 10 dB.
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Hoofdstuk 5
SAMENVATTING.
Het onderzoek naar genlokalisaties voor niet syndromale vormen van slechthorendheid heeft in de 
negentiger jaren een enorme vlucht genomen. Door de afdeling Keel-, Neus- en Oorheelkunde van het 
Academisch Ziekenhuis Nijmegen waren sedert het begin van de zeventiger jaren al veel families met 
erfelijke gehoorsverliezen bestudeerd. In 1994 werd een samenwerkingverband met de afdeling 
menselijke genetica van de Universiteit van Antwerpen gestart met als voornaamste doel het 
identificeren van de verantwoordelijke genen voor dominant overervende vormen van 
slechthorendheid. Tevens werd ten doel gesteld op grond van het genotype het erbij passende 
phenotype te beschrijven. Hierbij werd vaak een regressieanalyse van het gehoor verricht. Bij 
voorkeur werden grote families bestudeerd, dat wil zeggen families waarin naar verwachting 
tenminste 15 slechthorenden, met vermoedelijke een erfelijke aanleg daartoe, aanwezig waren. 
Inmiddels zijn ruim drie jaar na de start van deze klinische familiestudies bij de meeste van de 
betrokken families de verantwoordelijke mutaties gedetecteerd.
Het door de Europese Gemeenschap gefinancierde HEAR (Biomed) project versterkte een vruchtbare 
internationale samenwerking met andere genetische laboratoria. Deze internationale samenwerking 
heeft bijgedragen aan de in dit proefschrift beschreven resultaten.
De actuele stand van zaken is dat er thans 36 autosomaal dominante lokalisaties (DFNA1-36 ), 29 
autosomaal recessieve lokalisaties (DFNB1-29 ) en 8 geslachtsgebonden (DFN1-8) genlokalisaties 
zijn. Een serie nieuwe lokalisaties zijn al weer aangekondigd maar deze zijn nog niet gepubliceerd. 
Voor de maternale overerving zijn er twee mutaties gedetecteerd (Mt7475, Mt1555) die zich 
kenmerken door exclusieve niet syndromale slechthorendheid.
Voor een aantal syndromale slechthorendheden is het gen-defect inmiddels ook bekend. Deze 
genkoppeling en deze gen-identificatie hebben inmiddels geleid tot het beschrijven van het phenotype 
bij de desbetreffende families. In hoofdstuk 1 en 3 wordt een samenvatting van de thans bekende 
genlokalisaties voor niet syndromale vormen van autosomaal dominante slechthorendheid gegeven. 
Hoofdstuk 2 vermeldt de belangrijkste kenmerken van de maternale overerving. Het mitochondrieële 
genoom kent een inmiddels volledig opgehelderde sequentie. Overerving
verloopt strikt langs de maternale lijn. Klinische manifestaties correleren nauw met de 
energiebehoefte van het desbetreffende weefsel. Wij geven een klinische beschrijving van een nieuwe 
grote familie met een maternale overerving van met name slechthorendheid (Mt7472 ). Genotypering 
had plaats op de afdeling Medische Genetica van de Universitaire Instellingen te Antwerpen (Dr. G. 
Van Camp). Alle 69 maternaal gerelateerde individuen vertoonden een extra Cytosine insertie op 
positie 7472. Hoge tonen verlies was het vroegst presenterende symptoom. Lage tonen uitval trad
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vanaf het 10e levensjaar op. In het merendeel van de bestudeerde individuen was er sprake van een 
vestibulo-cerebellaire dysfunctie. Een open spier biopt verricht bij de probandus liet een deficiëntie 
zien in complex I en complex IV. Deze familie werd vergeleken met een Siciliaanse familie waar de 
identieke mitochondrieele mutatie werd beschreven. Er was sprake van een sterke overeenkomst in 
het ziektebeeld tussen de beide probandi alhoewel de leeftijd van initiële presentatie varieerde. De 
percentages van heteroplasmie varieerden niet significant tussen beide families. Deze percentages van 
heteroplasmie correleerden niet met de ernst van het gehoorverlies in de Nederlandse familie. 
Interfamiliaire verschillen waren er met name in de manifestatie van neurologische klachten.
Deze verschillen zijn mogelijk verklaarbaar op basis van andere factoren dan alleen heteroplasmie en 
leeftijd. Analyse van deze mutatie in families met een strikt maternaal gehoorsverlies met een 
volledige transmissie en een oligosymptomatisch neurologisch beeld heeft een plaats in de diagnostiek 
van de erfelijke slechthorendheid.
In hoofdstuk 3 wordt voor enkele Nederlandse families met niet syndromale vormen van autosomaal 
dominant overervende progressieve perceptieve gehoorverliezen (DFNA2, DFNA13) het phenotype 
en het genotype beschreven. Daar waar de vroegere tekstboeken deze erfelijke niet syndromale 
vormen van slechthorendheid indeelden op basis van het type audiogram zal dit voortaan geschiedden 
op basis van het verantwoordelijke gen defect. In het eerste deel van hoofdstuk 3 worden de 
kenmerken beschreven van drie Nederlandse families met DFNA2.
In alle drie families is de mutatie geïdentificeerd in het KCNQ4 gen. Onderlinge vergelijkingen van 
het phenotype van de Nederlandse families laten geen significante verschillen in het phenotype zien.
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Samenvatting en conclusies.
Het phenotype van de Indonesische familie vormt een uitzondering. In deze familie werd ook geen 
verandering in het KCNQ4 gen gedetecteerd. Regressie analyse van de audiometrische gegevens van 
de in hoofdstuk 3 beschreven Nederlandse DFNA2 familie “Dutch III” liet een "descending slope" 
zien van ongeveer 10 dB /octaaf met een "annual" threshold increase (ATI) van 0.7 dB/jr. De mutatie 
in deze familie bestaat uit een T naar A transversie op positie 821, die een Leucine doet veranderen 
in Tryptofaan (L274W). Deze verandering is gelokaliseerd in de P-loop domein van het KCNQ4 gen. 
De meeste mutaties in DFNA2 families bevinden zich in deze belangrijke regio.
Voor de hier beschreven familie met DFNA13 geldt dat dit de derde familie in de literatuur is die in 
dit gebied een genkoppeling blijkt te hebben. Voor de twee andere DFNA13 families is inmiddels het 
nieuwe gen met voor elk van deze families een andere mutatie van het gen gevonden. De hier 
beschreven familie heeft mogelijk een ander genotype binnen het gebied van DFNA13. Het vinden 
van meerdere genotypen is eerder zo voor DFNA2 gevonden. Toekomstig onderzoek zal hierover 
nadere kennis gaan verschaffen.
Ruim vijftig erfelijke syndromen met een aangeboren geleidingsslechthorendheid zijn beschreven. 
Beschrijvingen over de bevindingen bij middenoorchirurgie ter verbetering van het gehoor zijn in de 
literatuur schaars. Voor een viertal van deze syndromen worden in hoofdstuk 4 nieuwe bevindingen 
gepresenteerd.
Het Saethre-Chotzen syndroom is één van de craniosynotosis syndromen. Kleine mastoiden, ankylosis 
van de stapes alsmede een klein epitympanum met mogelijke fixatie van de hamer en het aambeeld 
maken reconstructieve oorchirurgie vaak moeilijk.
Reconstructie van de gehoorbeenketen kan dan in die gevallen vaak alleen succesvol geschieden door 
een nieuwe verbinding te maken tussen de hamersteel enerzijds en het vestibulum anderzijds.
Frequent is er tevens dysfunctie van de buis van Eustachius. Een BAHA (Bone Anchored Hearing 
Aid) kan, zoals voor één van deze patiënten beschreven wordt vanwege de tevens aanwezige 
chronische otitis media in deze gevallen, een goed alternatief zijn voor de revalidatie van het gehoor. 
Het Lacrimo-auriculo-dental-digital (LADD) syndroom kenmerkt zich door een combinatie van hand-, 
oor- en oogafwijkingen. De beschreven patiënte wordt
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gepresenteerd met een pre-operatieve air-bone gap van 60 dB; deze air-bone gap werd gesloten met 
behulp van een malleo-vestibulopexy.
De maxillofaciale dysostosis werd als een mogelijk nieuwe entiteit beschreven met een nog 
onbekende type overerving. Wij beschrijven twee broers met een phenotypisch uiterlijk dat bij een 
eerste oppervlakkige beschouwing past bij het Treacher Collins syndroom. Bij een nauwkeurige 
beschouwing blijkt het echter om een andere aandoening te gaan. Het overervingspatroon lijkt een X- 
gebonden of autosomaal recessieve erfgang te zijn. Als laatste worden de kenmerken beschreven van 
een autosomaal dominant overervend syndroom dat zich vooral kenmerkt door een proximaal 
symphalangisme met een conductief gehoorverlies. Het aangeboren gehoorverlies is het gevolg van 
een fixatie van delen van de gehoorbeenketen. De literatuur beschrijft voor dit syndroom zeer goede 
resultaten na stijgbeugelvervangende chirurgie. Wij presenteren de audiologische en chirurgische 
follow-up van twee Nederlandse broers alsmede een geïsoleerde Belgische patiënte met dit 
syndroom. Voor de twee Nederlandse patiënten bleek het uiteindelijke resultaat van 
middenoorchirurgie tegen te vallen. Naast een herhaald optredende luxatie van de 
stijgbeugelvervangende prothese trad bovendien een (her)fixatie van het korte been van het aambeeld 
op. Mogelijk treedt bij dit syndroom hernieuwde botvorming op van de stijgbeugelvoetplaat, wanneer 
deze slechts ten dele geopend wordt voor het plaatsen van een stijgbeugelvervangende piston. Het zou 
daarom kunnen zijn, dat het in dit syndroom, in tegenstelling tot de thans gangbare chirurgische 
techniek, beter is om de gehele stijgbeugelvoetplaat (stapedectomie) te verwijderen om deze 
complicatie te vermijden.
CONCLUSIE.
Tot slot kan opgemerkt worden dat in dit proefschrift opnieuw velerlei vormen van erfelijke 
slechthorendheid beschreven zijn. De beschreven mitochondriële overerving (Mt7472) is een 
verrassende en vrijwel nieuwe bevinding temeer nog omdat er een opvallende coïncidentie is voor 
drie personen van het intreden van een volledige doofheid na het gebruik van aminoglycosiden. De 
kennis over de niet syndromale vormen van autosomaal dominant en autosomaal recessief 
overervende binnenoorslechthorendheid en doofheid neemt als gevolg van de nieuwe succesvolle 
genetische technieken zeer snel toe. Voor DFNA2 beschrijft dit proefschrift één van de in totaal 6 
families met voor elke families een afzonderlijke mutatie. Het aangedane gen KCNQ4 is een kalium 
kanaal in de
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Hoofdstuk 5
haarcel. DFNA2 blijkt nog twee andere genotypes te kennen. Een daarvan is connexin 31 oftewel 
GJB.
Voor de groep syndromen met een aangeboren geleidingsslechthorendheid wordt het geleidelijk aan 
steeds vaker mogelijk om op basis van de mutatieanalyse de eerdere klinische diagnose te 
ondersteunen. Het nog beter leren kennen van de beste mogelijkheden ter revalidatie van het gehoor in 
deze zo bijzondere groep patiënten blijft ook voor de toekomst aangewezen.
De nieuwe mogelijkheden van gendiagnostiek hebben inmiddels al aangetoond dat er op het terrein 
van de erfelijke niet syndromale slechthorendheid en doofheid sprake is van een enorme genetische 
heterogeniteit. Het ziet er zelfs naar uit dat wij nog slechts aan het begin staan van een revolutionaire 
ontwikkeling bij het kunnen gaan herkennen van nog niet eerder beschreven niet syndromale vormen 
van erfelijke slechthorendheid. Moleculaire diagnostiek is voor sommige erfelijke vormen van niet 
syndromale vroegkinderlijke doofheid, zoals DFNB1 (connexin 26) inmiddels al in de reguliere 
medische praktijk als diagnostische mogelijkheid ter beschikking gekomen. Voor de klinische praktijk 
zullen de mogelijkheden op dit punt alleen maar verder gaan toenemen. Familiestudies, zoals hier 
beschreven, dragen bij tot het realiseren van andere belangrijke nieuwe ontwikkelingen, namelijk om 
op moleculair niveau de pathofysiologische veranderingen, die aan de beschreven erfelijke vormen 
van slechthorendheid ten grondslag liggen, te kunnen lezen. Het zijn juist die familiestudies die 
gecombineerd met de nieuwe laboratoriumtechnische mogelijkheden nu en in de nabije toekomst 
zullen blijven bijdragen aan onze nieuwe kennis over het functioneren van het gehoor.
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SUMMARY.
Research into gene localisations for non-syndromic forms of deafness expanded enormously in the 1990 
's. Since the beginning of the 1970 's, many families with hereditary hearing loss have been studied at the 
Ear, Nose and Throat Department of the University Hospital Nijmegen. In 1994 collaboration was 
started with the Human Genetics Department of Antwerp University with the primary aim of identifying 
the genes responsible for dominant hereditary forms of hearing loss. Another aim was to describe the 
phenotype on the basis of the genotype. For this purpose, it was often necessary to perform regression 
analysis on audiometric data.
We preferably studied large families, i.e. in which at least 15 hearing impaired individuals were expected 
to have a hereditary predisposition. At present, more than three years after the start of this clinical family 
study, we have detected the mutations responsible in the majority of families studied.
The HEAR (Biomed) project, financed by the European Community, has enabled fruitful international 
collaboration with other genetic laboratories. This international collaboration has contributed to the 
results presented in this thesis.
At present, 36 autosomal dominant localisations (DFNA 1-36), 29 autosomal recessive localisations 
(DFNB1-29) and 8 sex-linked (DFN1-8) gene localisations have been identified. A series of new 
localisations has been announced, but not yet published. Two maternally transmitted mutations have 
been detected (Mt 7475, Mt 1555) which are characterised exclusively by non-syndromic hearing loss. 
The gene defect has also been identified for a number of syndromic types of hearing loss. This gene 
linkage and gene identification have led to the description of the phenotype in several of the families. 
Chapters 1 and 3 summarize the present state of knowledge on gene localisations for non-syndromic 
forms of hereditary hearing loss.
Chapter 2 describes the major characteristics of maternal transmission. The sequence of the 
mitochondrial genome has now been fully-clarified. Transmission occurs strictly along the maternal line. 
Clinical manifestations correlate closely with the energy requirements of the tissues concerned. We 
describe the clinical findings in a new large family with maternal transmission of hearing loss (Mt 
7472). Genotyping took place at the Human Genetics
Chapter 5
Department of Antwerp University (Dr. G. Van Camp). All 69 maternally related individuals showed an 
extra Cytosine insertion at position 7472. High frequency impairment was presenting symptom. Low 
tone hearing loss started at the age of 10 years. The majority of these individuals had vestibulo-cerebellar
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dysfunction. An open muscle biopsy obtained from the proband showed deficiencies in complex I and 
complex IV of the respiratory chain.
This family was compared to a Sicilian family who are described as having an identical mutation 
(Mt7472). There were strong similarities in symptoms between the two probands, although the age of 
initial presentation differed. The percentages of heteroplasmia did not vary significantly between the two 
families. These percentages of heteroplasmia did not correlate with the severity of hearing loss in the 
Dutch family. Interfamilial symptoms were present mainly in the manifestation of neurological 
complaints.
These differences might be explained on the basis of other factors besides heteroplasmia and age. 
Analysis of this mutation in families who have strict maternally transmitted hearing loss, with full 
transmission, and oligosymptomatic neurological symptoms, has a place in the diagnosis of hereditary 
hearing loss.
Chapter 3 describes the phenotype and the genotype in several Dutch families with non-syndromic forms 
of autosomal dominant hereditary progressive perceptive hearing loss (DFNA2, DFNA13). Whereas 
earlier textbooks classified these hereditary non-syndromic forms of hearing loss on the basis of the type 
of audiogram, they can now be classified on the basis of the gene responsible for the defect. The third 
part of Chapter 3 describes the characteristics of 3 Dutch families with DFNA2.
In all three families, the mutation has been identified in the KCNQ4 gene. Comparison of the phenotypes 
between the Dutch families did not reveal any significant differences in phenotype, with the exception of 
the phenotype of the Indonesian family. In the latter family, no changes in the KCNQ4 gene were 
detected. Regression analysis on the audiometric data from the Dutch DFNA2 family ( Dutch III) 
described in Chapter 3 showed a descending slope of about 10 dB/octave with a threshold increase 
(ATI) of 0.7 dB/year.
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The mutation comprises a T to A transversion at position 821, which changes Leucine into Tryptophane 
(L274W). This transversion is localised in the P-loop domain of the KCNQ4 gene. The majority of 
mutations in DFNA families occur in this important region.
The DFNA13 family described in this thesis constitutes the third family in the literature with gene 
linkage in this region. In the other two DFNA13 families, the new gene has been found to have 
another mutation. The family described in this thesis may have another genotype within the DFNA13 
region. Multiple genotypes have also been found for DFNA2. Future research will provide greater 
knowledge on this issue.
Over 50 hereditary syndromes with congenital conductive hearing loss are reported in literature. 
However, there are few reports on reconstructive middle ear surgery that aimed to improve patient's 
hearing. New findings are presented for four of these syndromes in Chapter 4.
The Saethre-Chotzen syndrome is one of the craniosynotosis syndromes. Small mastoids, ankylosis of 
the stapes and a small epitympanum with possible fixation of the malleus and incus often make 
reconstructive surgery difficult. In such cases, reconstruction of the ossicular chain can only be achieved 
by making a new connection between the handle of the malleus and the vestibulum. A frequent 
accompanying feature is dysfunction of the Eustachian tube. As has been described in one of these 
patients, a BAHA (Bone Anchored Hearing Aid) can form a good alternative for hearing rehabilitation, 
particularly in view of the prevalence of chronic otitis media in these patients.
The Lacrimo-auriculo-dental-digital (LADD) syndrome is characterised by a combination of hand, ear 
and eye abnormalities. The patient described presented with a pre-operative air-bone gap of 60 dB; this 
air-bone gap was closed by means of a malleo-vestibulopexy.
Maxillo-facial dysostosis is described as a possible new entity, with an unknown pattern of inheritance. 
We described two brothers with a phenotypical appearance that at first seemed to fit the Treacher Collins 
syndrome. However, careful examination revealed that they were suffering from a different condition. 
The pattern of inheritance appears to be X-linked or autosomal recessive.
We also encountered an autosomal dominant hereditary syndrome that was particulary characterised by 
proximal symphalangism and conductive hearing loss.
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Summary and Conclusions
The congenital hearing loss was the result of fixation of parts of the ossicular chain. In the literature, 
very good results have been reported with stapes replacement surgery in these patients. We present the 
audiological and surgical follow-up of two Dutch brothers and an isolated Belgian patient with this 
syndrome. In the two Dutch patients, the ultimate result of middle ear surgery was disappointing. They 
experienced repeated luxation of the stapedial prosthesis and (re)fixation of the short arm of the incus. It 
is possible that this syndrome is associated with new bone formation at the stapedial footplate when this 
structure is partially opened to receive the stapedial piston. In patients with this syndrome, it might be 
better to deviate from the current surgical technique and remove the stapedial footplate completely 
(stapedectomy) in order to avoid these complications.
CONCLUSIONS.
Many forms of hereditary hearing impairment have been described in this study. The mitochondrial 
transmission (Mt7472) is a surprising and very new finding. It deserves particular mention in view of 
the striking coincidence of three persons becoming totally deaf after using aminoglycosides. 
Knowledge on the non-syndromic forms of autosomal dominant and autosomal recessive hereditary 
sensorineural hearing impairment and deafness is increasing rapidly owing to the new successful 
genetic techniques. This thesis describes one of the six DFNA2 families with separate mutations.
The affected gene, KCNQ4, is a potassium canal in hair cells. DFNA2 also has two other genotypes. 
One of them is connexin 31, or GJB.
On the basis of mutation analysis (genotyping) it is becoming increasingly possible to confirm the 
clinical diagnosis (phenotype) of patients with the group of syndromes with congenital conductive 
hearing loss. Future research is necessary to determine the best rehabilitation options for this 
remarkable group of patients.
The new data from genetic diagnosis have shown that there is enormous heterogeneity in the field of 
hereditary non-syndromic hearing impairment and deafness. It even appears that we have only 
scratched the surface of a revolutionary development in which it will
become possible to identify non-syndromic forms of hereditary deafness that have never been 
described before.
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Molecular diagnosis is available in regular medical practice for some hereditary forms of non- 
syndromic early childhood hearing loss, like for DFNB1 ( connexin 26). It can be expected that these 
facilities will expand greatly in clinical practice in the future. Family studies, such as those described 
in this thesis, contribute to the realisation of other important new developments: for instance being 
able to read the pathophysiological changes underlying the hereditary forms of hearing loss on a 
molecular level. Particularly family studies in combination with the new laboratory techniques will 
continue to increase our knowledge on the function of hearing.
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